clarithromycin has been researched along with rifampin in 348 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (0.57) | 18.7374 |
| 1990's | 59 (16.95) | 18.2507 |
| 2000's | 107 (30.75) | 29.6817 |
| 2010's | 140 (40.23) | 24.3611 |
| 2020's | 40 (11.49) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, B; Johar, M; Kumar, R; Kunimoto, DY; Manning, T; Rai, D | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Kumar, R; Kunimoto, DY; Manning, T; Srivastav, NC | 1 |
| Agrawal, B; Desroches, N; Johar, M; Kumar, R; Kunimoto, DY; Manning, T; Tse, C | 1 |
| Chauffour, A; Jarlier, V; Ji, B; Lefrançois, S; Robert, J | 1 |
| Agrawal, B; Johar, M; Kumar, R; Kunimoto, DY; Manning, T; Rai, D; Srivastav, NC | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Campbell, BJ; Edwards, SW; Hart, CA; Martin, HM; Rhodes, JM; Roberts, CL; Subramanian, S | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Apajalahti, J; Fox, J; Frimodt-Møller, N; Hansen, F; Loidl, G; Nagai, J; Siikanen, O; Takano, M; Vaara, M; Vaara, T | 1 |
| Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
| Chen, H; Chen, M; Liu, Y; Ma, Y; Nichols, WW; Sun, W; Wang, H; Zhang, J; Zhao, C | 1 |
| Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bishai, WR; Grosset, JH; Nuermberger, EL; Zhang, T | 1 |
| Apajalahti, J; Fox, J; Frimodt-Møller, N; He, H; Li, J; Nation, RL; Poudyal, A; Siikanen, O; Vaara, M; Vaara, T | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Bohnert, JA; Karamian, B; Nikaido, H | 1 |
| Biedenbach, DJ; Castanheira, M; Jones, RN | 1 |
| Parra-Ruiz, J; Rose, WE; Rybak, MJ; Vidaillac, C | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Agrawal, A; Bhavanam, S; Desroches, N; Kumar, R; Kunimoto, DY; Shakya, N; Srivastav, NC; Tse, C | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Agrawal, B; Bhavanam, S; Desroches, N; Kumar, R; Kunimoto, DY; Shakya, N; Srivastav, NC; Tse, C | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Fruziński, A; Gamian, A; Karczmarzyk, Z; Malinka, W; Sliwińska, M; Swiątek, P; Szponar, B | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bharate, SS; Vishwakarma, RA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Agrawal, A; Garg, G; Kumar, R; Li, J; Pande, M | 1 |
| Agrawal, B; Garg, S; Kumar, R; Kunimoto, DY; Shakya, N; Srivastav, NC | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Augustinović, M; Burdette, JE; Falkinham Iii, JO; Flores-Bocanegra, L; Heath-Borrero, KN; Knowles, SL; Oberlies, NH; Pearce, CJ; Raja, HA; Roberts, CD | 1 |
| Chen, J; Ding, C; Doyle, T; Duncan, L; Ebright, RH; He, S; Lin, W; Liu, Y; Lynch, AS; Ma, Z; Molodtsov, V; Nguyen, P; Pulse, M; Robertson, GT; Wang, H; Weiss, WJ; Xu, X; Yuan, Y; Zhuang, Z | 1 |
| Cynamon, MH; DeStefano, MS; Klemens, SP | 1 |
| Grosset, JH; Ji, B; Perani, EG; Petinon, C | 1 |
| Cynamon, MH; Klemens, SP; Swenson, CE | 1 |
| Gikas, A; Grosset, J; Perronne, C; Pocidalo, JJ; Truffot-Pernot, C; Vilde, JL | 1 |
| Labrousse, V; Rastogi, N | 1 |
| Grosset, JH; Ji, B; Perani, EG | 1 |
| Berlie, HC; Chevret, S; Dautzenberg, B; Grosset, J; Legris, S; Mercat, A; Meyohas, MC; Truffot, C | 1 |
| Baltch, AL; Conroy, JV; Hammer, MC; Liebers, DM; Smith, RP | 1 |
| Anderson, R; Joone, G; van Rensburg, CE | 1 |
| Jadavji, T; Kuhn, SM; Rosen, W; Wong, A | 1 |
| Chehl, SK; Gelber, RH; Murray, LP; Richard, V; Siu, P; Tsang, M | 1 |
| Delia, S; Iona, E; Mascellino, MT; Mastroianni, CM; Ponzo, R | 1 |
| Carreres, A; Domingo, C; Roig, J | 1 |
| Kabe, J; Kotajima, F; Kudo, K; Sugiyama, H; Yagishita, Y; Yoshizawa, A | 1 |
| Echávarri, B; Marco, ML; Remacha, A | 1 |
| Brown, BA; Girard, W; Griffith, DE; Tanaka, K; Wallace, RJ | 1 |
| Allen, NB; Corey, GR; Darling, TN; Kamino, H; Murray, JC; Sidhu-Malik, N | 1 |
| Cynamon, MH; Klemens, SP | 1 |
| Hasegawa, N; Kanazawa, M; Kawashiro, T; Sakamaki, F; Terashima, T | 1 |
| Dusart, G; Simeon De Buochberg, M; Ximenes, E; Zuccarelli, M | 1 |
| Shinnick, TM; Van Landingham, RM; Walker, LL | 1 |
| Hjelm, U; Hoffner, SE; Källenius, G | 1 |
| Clark, JA; Margolis, DM | 1 |
| Gidoh, M; Saito, H | 1 |
| Daneluzzi, D; Gangadharam, PR; Luna-Herrera, J; Reddy, VM | 1 |
| Asnis, DS; Bresciani, AR; Cohn, M | 1 |
| Brown, BA; Girard, WM; Griffith, DE; Murphy, DT; Wallace, RJ | 1 |
| Fanning, MM; Fong, IW; Gill, MJ; Lalonde, RG; Phillips, P; Rachlis, AR; Salit, I; Shafran, SD; Singer, J; Tsoukas, CM; Walmsley, SL; Zarowny, DP | 1 |
| Grosset, JH; Ji, B; Perani, EG; Petinom, C | 1 |
| Amitani, R; Kuze, F; Murayama, T; Suzuki, K; Tanaka, E; Yamamoto, T | 1 |
| Coker, RJ; Fisher, M; Tomlinson, DR | 1 |
| Tanaka, E | 1 |
| Banerjee, DK; McDermott-Lancaster, RD; McKenzie, S | 1 |
| Flisch, CW; Santa, DD; Zuber, C | 1 |
| Borderas, F; Delgado, J; Gallardo, JA; Leal, M; Lissen, E; Macías, J; Pineda, JA; Sánchez-Quijano, A | 1 |
| Brady, RC; Goderwis, D; Mayer, T; Schleiss, MR; Sheth, A | 1 |
| Garces, MC; McAllister, CK; Plemmons, RM; Ward, RL | 1 |
| Gabl, M; Hausdorfer, H; Kreczy, A; Pechlaner, S; Went, P | 1 |
| Fuursted, K | 1 |
| Esfandiari, A; Mor, N | 1 |
| Baraia-Etxaburu, J; Cisterna, R; Malero, P; Muñoz, J; Santamaría, JM; Teira, R; Unzaga, MJ | 1 |
| Burman, WJ; Cohn, DL; Reves, RR; Rietmeijer, CA | 1 |
| Bryskier, A; Hoppe, JE | 1 |
| Horgen, L; Legrand, E; Rastogi, N | 2 |
| Horgen, L; Jerome, A; Rastogi, N | 1 |
| Ansorg, R; Fabry, W; Schmid, EN | 1 |
| Coward, RA; Kistler, A; Lappin, DW | 1 |
| Calhoun, J; Mader, JT; Shirtliff, ME | 1 |
| de Jong, JJ; Endtz, HP; IJzermans, JN; van Gelder, T; Weimar, W | 1 |
| Dubois, J; St-Pierre, C | 1 |
| Amitani, R; Kimoto, T; Kuze, F; Matsumoto, H; Murayama, T; Niimi, A; Suzuki, K; Tanaka, E; Tsuyuguchi, K; Watanabe, I | 1 |
| Berning, SE; Gilljam, M; Larsson, LO; Peloquin, CA; Strandvik, B | 1 |
| Allan, GS; Davis, W; Foster, SF; Malik, R; Martin, P; Mitchell, DH | 1 |
| Stengel, W | 1 |
| Komatsu, H; Tabata, N; Tagami, H; Terunuma, A | 1 |
| Koromihis, G; Libman, M; MacLean, JD; Semret, M; Ward, BJ | 1 |
| Khorasheh, S; Lemieux, C; Raboud, JM; Salit, I; Shafran, SD; Singer, J; Thorne, A; Tsoukas, CM; Wu, AW | 1 |
| Bottura, P; Capra, R; Maggiolo, F; Migliorino, M; Pravettoni, G; Suter, F | 1 |
| Kihara, Y; Otsuki, M | 1 |
| Ebe, T; Sato, K | 1 |
| Lanternier, G; Le Vagueresse, R; Saint-Blancard, P; Samson, T; Schmoor, P; Soler, C | 1 |
| Barchiesi, F; Cirioni, O; Giacometti, A; Scalise, G | 1 |
| Rea, TH | 1 |
| Chen, SC; Furber, H; Hughes, MS; James, G; Love, DN; Lucas, A; Lucas, J; Malik, R; Martin, P; Mitchell, DH | 1 |
| Jiang, Q; Taylor, DE; Wang, G; Wilson, TJ | 1 |
| Allen, J; Chen, SC; Cibilic, D; Hughes, MS; Love, DN; Malik, R; Martin, P; Mitchell, DH; Sattler, PS; Slatter, PS; Swan, D; Wigney, D | 1 |
| Bermudez, LE; Cangelosi, GA; Palermo, CO | 1 |
| Foustoukou, M; Ioannidou, S; Kotsovili-Tseleni, A; Legakis, NJ; Tassios, PT; Vatopoulos, A | 1 |
| Abété, B; Scotté, M; Songné, B; Tchangaï-Walla, KL; Tignokpa, N; Valenti, P | 1 |
| Kashiwabara, Y; Matsuoka, M; Namisato, M | 1 |
| Cheng, B | 1 |
| Bowersox, J | 1 |
| Asada, K; Inui, N; Kuwata, H; Matsuda, H; Nakamura, H; Nakamura, Y; Sennda, K; Suda, T; Suzuki, K; Tsuchiya, T; Yokomura, K | 1 |
| Ena, P; Lorrai, MP; Molicotti, P; Saccabusi, S; Sechi, LA; Siddi, M; Zanetti, S | 1 |
| Carabias, ML; Cervera, LA; entelles, ML; García-Navas, BL | 1 |
| Andersson, DI; Berg, OG; Björkholm, B; Engstrand, L; Falk, PG; Sjölund, M | 1 |
| Brandi, G; Celeste, AG; Salvaggio, L; Schiavano, GF; Sisti, M | 1 |
| McEwan, JA; McKendrick, MW; Mohsen, AH; Schmid, ML | 1 |
| Fujimura, S; Kato, S; Kawamura, T; Watanabe, A | 1 |
| Canfield, PJ; Chen, SC; Hughes, MS; James, G; Love, DN; Malik, R; Martin, P; Mitchell, DH; Wigney, DI | 1 |
| Badsha, H; Chong, AP; Kong, KO; Teh, CL | 1 |
| Guédénon, A; Hans-Moevi, A; Houessou, R; Ifebe, D; Johnson, RC; Kestens, L; Meyers, WM; Portaels, F | 1 |
| Batra, V; Niazi, S; Zangrilli, JG | 1 |
| Bentoucha, A; Dega, H; Grosset, J; Jarlier, V; Robert, J | 1 |
| Campbell, J; Eskenazi, AE; Suryanarayan, K | 1 |
| Cadeo, B; Colombini, P; Cristini, F; Matteeli, A; Signorini, L; Simeone, F; Tonegatti, L; Viale, P | 1 |
| Dailloux, M; Dauendorffer, JN; Laurain, C; Weber, M | 1 |
| Arnold, P; Dietrich, U; Guscetti, F; Pfyffer, GE; Spiess, B | 1 |
| Sano, C; Sano, K; Sato, K; Shimizu, T; Tomioka, H | 1 |
| Fitoussi, F; Jehanno, P; Journeau, P; Padovani, JP; Pennecot, GF | 1 |
| Nagai, H | 1 |
| Kobashi, Y; Matsushima, T | 3 |
| Forslöw, U; Geborek, A; Heurlin, N; Hjelte, L; Petrini, B | 1 |
| Allen, M; Callaghan, R | 1 |
| Bhaloo, S; Prasad, GV | 1 |
| Brans, R; Poblete-Gutiérrez, P; Rübben, A | 1 |
| Harada, S; Harada, Y; Kitahara, Y; Mitsuyama, T; Nakanishi, Y; Yamamoto, F; Yoshida, M | 1 |
| Adler, H; Bär, G; Hammer, J; Heininger, U; Schulzke, S | 1 |
| Fox, R; Mears, J | 1 |
| Barker, TA; Clarke, B; Denley, H; Grötte, GJ; Kadir, IS | 1 |
| Hess, CL; Murphy, MS; Wolock, BS | 1 |
| Bakker-Woudenberg, IA; van Agtmael, MA; van Soolingen, D; van Vianen, W; Verbrugh, HA | 1 |
| Berthold, F; Ebeling, O; Handrick, W; Schwede, I; Wogawa, B | 1 |
| Bar, T; Lewkowicz, A; Mishal, J; Nahlieli, O | 1 |
| Contios, S; Genestet, M; Le Nen, D; Roguedas, AM; Volant, A | 1 |
| Catherinot, E; Gaillard, JL; Le Bourgeois, M; Sermet-Gaudelus, I | 1 |
| Aizawa, H; Kinoshita, T; Rikimaru, T; Yokoyama, T | 1 |
| Bhusal, Y; Shiohira, CM; Yamane, N | 1 |
| Chimara, E; da Silva Telles, MA; Ferrazoli, L; Riley, LW | 1 |
| Corti, ME; Palmero, DJ | 1 |
| Barone, GW; Breen, P; Carrier, J; Cheboyina, S; Gurley, BJ; Hubbard, MA; Song, PF; Tong, Y; Williams, DK; Yates, CR | 1 |
| Fujiwara, K | 1 |
| Cai, S; Hiraki, M; Sano, C; Sato, K; Shimizu, T; Tomioka, H; Yamabe, S | 1 |
| Breen, P; Carrier, DJ; Cheboyina, S; Gentry, WB; Gurley, B; Hubbard, MA; Thaden, J; Tong, Y; Williams, DK | 1 |
| Aksamit, TR; Catanzaro, A; Daley, CL; Garay, SM; Griffith, DE; Lam, PK; Ruoss, SJ | 1 |
| Baum, GL; Daniele, B; Kramer, MR; Lavy, A; Priess, R; Raz, M; Shitrit, AB; Shitrit, D; Shlomi, D | 1 |
| Izumi, S; Taniguchi, H | 1 |
| Huggon, A; Umrawsingh, A | 1 |
| Antonio, JM; Garau, J; Garcés, JM; Grau, S; Ribes, E; Salvadó, M | 1 |
| Allison, RW; Hylton, PK; Rizzi, TE | 1 |
| Boswinkel, M; Sloet van Oldruitenborgh-Oosterbaan, MM | 1 |
| Brumble, L; Garland, JL; Johnson, MM; Khoor, A; Roy, A; Waller, EA | 1 |
| Gidoh, M; Matsuoka, M; Yamazaki, T | 1 |
| Barone, GW; Breen, P; Cheboyina, S; Gurley, BJ; Hubbard, MA; Stuart, LB; Swain, A; Tong, Y; Williams, DK; Yates, CR | 1 |
| Falkinham, JO | 1 |
| Burroughs, RF; Cho, S; Johnson, RP; Krivda, SJ; Xia, Y | 1 |
| Kurashima, A | 1 |
| Gentry, WB; Gurley, BJ; Hartsfield, F; Hubbard, MA; Swain, A; Thaden, J; Tong, Y; Williams, DK | 1 |
| Boeree, M; de Haas, P; de Lange, W; Dekhuijzen, R; Janssen, M; Ullmann, E; van Ingen, J; van Soolingen, D | 1 |
| Nakagawa, T; Nikai, T; Ogawa, K; Taki, H | 1 |
| Bakker-Woudenberg, IA; de Steenwinkel, JE; Schiffelers, RM; Ten Kate, MT; van Agtmael, MA; van Vianen, W; Verbrugh, HA | 1 |
| Kashima, K; Nakagawa, T; Nikai, T; Ogawa, K; Saitou, Y; Taki, H; Tano, M; Tarumi, O; Yamada, N | 1 |
| Matsuki, A; Saito, K; Suzuki, K; Tanaka, Y | 1 |
| Kurita, S; Nagatake, T; Oishi, K; Watanabe, H | 1 |
| Barone, G; Battu, SK; Gurley, BJ; Swain, A; Williams, DK | 1 |
| Banks, J; Campbell, IA; Gelder, CM; Jenkins, PA; Prescott, RJ; Smith, AP | 1 |
| Amir, J; Bilavsky, E; Eliahou, R; Harel, L; Keller, N; Yarden-Bilavsky, H | 1 |
| Kurashima, A; Mikami, J; Mita, M; Nishimura, T; Ohtawa, S; Saito, M; Suzuki, A | 1 |
| Chauffour, A; Jarlier, V; Ji, B; Robert, J | 1 |
| Faruqi, S; Kastelik, JA; McGivern, DV | 1 |
| Hill, AT; Laurenson, IF; Murray, MP | 1 |
| Affolabi, D; Anagonou, SY; Asiedu, K; Barogui, YT; Dossou, AD; Johnson, CR; Portaels, F; Sopoh, GE; Zohoun, T | 1 |
| Breda, L; Chiarelli, F; de Michele, G; De Sanctis, S; Di Marzio, D; Nozzi, M | 1 |
| Kobashi, Y; Oka, M | 1 |
| Alffenaar, JW; de Velde, F; Greijdanus, B; Uges, DR; Wessels, AM | 1 |
| Fukunaga, K; Hasegawa, N; Ishii, K; Ishizaka, A; Miyairi, M; Nishimura, T; Ohtani, S; Takeshita, K; Tasaka, S; Urano, T | 1 |
| Agudo, S; Alarcón, T; Cibrelus, L; López-Brea, M; Martínez, MJ; Urruzuno, P | 1 |
| Boehler, A; Gaspert, A; Irani, S; Lienhardt, B; Weishaupt, D | 1 |
| Chin, BS; Choi, HK; Choi, JY; Choi, SH; Han, SH; Jeong, SJ; Kim, CO; Kim, JM; Kim, KM; Kim, MS; Lee, HS; Song, YG | 1 |
| Bennett, T; Rust, PA | 1 |
| Abass, KM; Adjei, O; Ampadu, EO; Awua-Boateng, NY; Awuah, PC; Bretzel, G; Nienhuis, WA; Schouten, JP; Siegmund, V; Stienstra, Y; Thompson, WA; Tuah, W; van der Werf, TS | 1 |
| Phan, TA; Relic, J | 1 |
| Apajalahti, J; Frimodt-Møller, N; Siikanen, O; Vaara, M; Vaara, T | 1 |
| Billal, DS | 1 |
| Ezzedine, K; Guir, V; Malvy, D; Pistone, T | 1 |
| Adjei, O; Alffenaar, JW; Almeida, D; de Velde, F; Grosset, J; Nienhuis, WA; Uges, DR; van der Werf, TS; Wessels, AM; Zuur, AT | 1 |
| Jeon, K; Koh, WJ; Kwon, OJ; Park, HY; Sim, YS; Suh, GY | 1 |
| Krimer, PM; Miller, DM; Phillips, KM; Sanchez, S | 1 |
| Adeye, A; Ardant, MF; Chauty, A; Cottin, J; Goundoté, A; Ji, B; Ladikpo, T; Landier, J; Marsollier, L; Pluschke, G; Ruf, T | 1 |
| Ahmad, Z; Almeida, D; Converse, PJ; Dooley, KE; Grosset, JH; Nuermberger, EL | 1 |
| Oswald, S; Peters, J; Siegmund, W; Venner, M | 1 |
| Fusama, M; Hamano, Y; Higa, S; Hosokawa, T; Igarashi, T; Kamide, Y; Kawamoto, K; Kuritani, T; Kuroiwa, T; Lin, Y; Maeda, K; Nakahara, H; Nishide, M | 1 |
| Alffenaar, JW; Uges, DR; van der Elst, KC | 1 |
| Girdhar, A; Girdhar, BK; Kumar, A | 1 |
| Block, W; Freyer, J; Grube, M; Kroemer, HK; Lämmer, M; Lütjohann, D; Oswald, S; Peters, J; Siegmund, W; Venner, M | 1 |
| Aïssi, E; Ettahar, N; Huleux, T; Massongo, M; Melliez, H; Pasquet, A; Yazdanpanah, Y | 1 |
| Duchin, JS; Kay, MK; Perti, TR | 1 |
| Fujita, M; Harada, E; Ikegame, S; Kajiki, A; Matsumoto, T; Miyazaki, M; Nakanishi, Y; Ouchi, H; Tao, Y; Uchino, J; Watanabe, K | 1 |
| Alonso, M; Del Pozo, JL; Francés, ML; Hernáez, S; Rubio, MF; Serrera, A | 1 |
| Breda, R; Janvier, F; Macnab, C; Rigal, S | 1 |
| Hoshino, Y; Ishii, N; Nakanaga, K; Onoe, H; Takeuchi, T; Yotsu, RR | 1 |
| Block, W; Eggers, K; Lämmer, M; Lütjohann, D; Oswald, S; Peters, J; Siegmund, W; Venner, M | 1 |
| Abe, M; Kato, S; Kobashi, Y; Mouri, K; Obase, Y; Oka, M | 1 |
| Ankomah, P; Levin, BR | 1 |
| Brochot, P; Desplaces, N; Direz, G; Eschard, JP; Salmon, JH; Ziza, JM | 1 |
| Bircher, AJ; Brož, P; Grize, L; Harr, T; Hecking, C; Jaeger, KA; Scherer, K | 1 |
| Cajigas-Pezo, D; Lorenzo-Hernandez, A; Rentero-Martínez, Z; Vives-Rivero, GR | 1 |
| Hassan, G; Kant, S; Parengal, J; Saheer, S | 1 |
| Aarnoutse, RE; Boeree, MJ; Daley, CL; Egelund, EF; Heifets, LB; Levin, A; Mouton, JW; Peloquin, CA; Totten, SE; van Ingen, J | 1 |
| Abeygunasekara, S; Chan, A; Findlay, A | 1 |
| Jeon, K; Jeong, BH; Koh, WJ; Lee, SY; Shin, SJ | 1 |
| Abe, M; Ichiki, H; Sato, C; Ueda, S; Watanabe, A | 1 |
| Alffenaar, JW; Greijdanus, B; Koster, RA; Uges, DR; Vu, DH; Wessels, AM | 1 |
| Gochi, M; Kaneko, Y; Kinoshita, A; Kuwano, K; Saitou, Z; Samejima, T; Seki, A; Seki, Y; Takeda, H | 1 |
| Hong, G; Jeon, K; Jeong, BH; Kim, CK; Kim, SY; Koh, WJ; Kwon, OJ; Lee, SH; Park, HY; Shin, SJ | 1 |
| Feng, SY; Wang, HS; Wang, QL; Zhou, L | 1 |
| Benne, MS; Greupink, R; Huisman, MT; Russel, FG; Schreurs, M | 1 |
| Maruyama, S; Murai, A; Nagata, M; Yuki, M | 1 |
| Athan, E; Callan, P; Friedman, ND; Hughes, AJ; Khajehnoori, M; McDonald, A; O'Brien, DP; Rahdon, R | 1 |
| Denno, K; Horiki, M; Minoda, Y; Tada, K; Yano, K; Yoneda, M; Yoshida, T | 1 |
| Berghaus, LJ; Giguère, S; Guldbech, K | 1 |
| Jeong, BH; Jeong, YJ; Kim, HJ; Koh, WJ; Lee, G; Lee, KS; Moon, JW; Woo, S | 1 |
| Alcántara, F; Atwood, SS; Becerra, MC; Bonilla, CA; Mitnick, CD; Seung, KJ | 1 |
| Chida, K; Hayakawa, H; Inui, N; Masuda, M; Miwa, S; Shirai, M; Shirai, T; Suda, T; Toyoshima, M; Yamada, T; Yasuda, K; Yokomura, K | 1 |
| Abass, MK; Abotsi, J; Amoako, YA; Asiedu, K; Forson, M; Phillips, RO; Sarfo, FS; Thompson, W; Wansbrough-Jones, M; Wilson, T | 1 |
| Cho, SN; Jeon, K; Kim, SY; Koh, WJ; Kwon, OJ; Park, HY; Shin, SJ | 1 |
| Arends, JE; Formanoy, E; Lam, HY | 1 |
| Imamura, Y; Izumikawa, K; Kakeya, H; Kohno, S; Miyazaki, T; Nakamura, S; Takazono, T; Yanagihara, K | 1 |
| Alffenaar, JW; Altena, RV; Bolhuis, MS; Brouwers, JR; Greijdanus, B; Koster, RA; Nguyen, DH; Uges, DR; Vu, DH | 1 |
| Aucamp, ME; de Villiers, MM; Miller, Z; Otto, DP; Rose, WE | 1 |
| Fahy, R; Keane, J; Lyons, J; McDonnell, C; McLaughlin, AM; Vandenberghe, E | 1 |
| Kingma, R; Klis, S; Stienstra, Y; Tuah, W; van der Werf, TS | 1 |
| Abass, MK; Amoako, YA; Ampadu, E; Asiedu, K; Forson, M; Frimpong, M; Phillips, RO; Sarfo, FS; Thompson, W; Wansbrough-Jones, M | 1 |
| Ghrew, MH; Gornasa, M; Lavery, K; O'Riordan, E; Walsham, A; Wilding, T | 1 |
| Fujita, K; Hirai, T; Ichiyama, S; Ito, Y; Kubo, T; Maekawa, K; Mishima, M; Togashi, K | 1 |
| Daley, CL; Huh, HJ; Jeon, K; Jeong, BH; Ki, CS; Kim, SY; Koh, WJ; Lee, KS; Lee, NY; Park, HY; Shin, SJ | 1 |
| Athan, E; Callan, P; Cowan, R; Friedman, ND; Fyfe, J; Hughes, AJ; McDonald, A; O'Brien, DP | 1 |
| Arnold, RD; Berghaus, LJ; Burton, AJ; Giguère, S; Hondalus, MK | 1 |
| Aihara, M; Ishii, N; Makigami, K; Nakanaga, K; Sugawara, M; Suzuki, K; Umebayashi, Y | 1 |
| Berghaus, LJ; Burton, AJ; Giguère, S; Hondalus, MK | 1 |
| Adamson, J; Converse, PJ; Grosset, JH; Kishi, Y; Li, SY; Nuermberger, EL; Tyagi, S; Xing, Y | 1 |
| Hill, FJ; McCloskey, SJ; Sheerin, N | 1 |
| Zhang, T | 1 |
| Chowdhary, M; Kumar, RA; Narsinghani, U | 1 |
| Albano, A; De Marchi, S; di Meo, N; Stinco, G; Trevisan, G; Trevisini, S | 1 |
| Altboum, Z; Bar-David, E; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S | 1 |
| Burgner, D; Buttery, J; Carr, J; Chan, Y; Ditchfield, M; Hollitt, A | 1 |
| Akiyama, M; Betsuyaku, T; Hasegawa, N; Ishii, M; Kohno, M; Namkoong, H; Suzuki, K; Takeuchi, T; Tasaka, S; Yagi, K | 1 |
| Berlin, S; Grube, M; Hasan, M; Keiser, M; Lumpe, S; Oswald, S; Siegmund, W; Spieckermann, L; Ullrich, A; Venner, M | 1 |
| Connell, T; Curtis, N; Gonis, G; Leslie, D; MacGregor, D; Pantazidou, A; Ritz, N; Sedda, L; Tebruegge, M | 1 |
| Bohnert, JA; Handzlik, J; Kaczor, A; Karcz, T; Kern, WV; Kieć-Kononowicz, K; Olejarz, A; Schuster, S | 1 |
| Athan, E; Friedman, ND; O'Brien, DP; Walton, AL | 1 |
| Imanishi, S; Kadota, N; Naito, N; Ogushi, F; Okano, Y; Shinohara, T; Takahashi, N; Taoka, T | 1 |
| Chande, N; MacDonald, JK; Parker, CE; Patton, PH | 1 |
| Ariza, J; Cabellos, C; Cabo, J; El Haj, C; Garcia-Somoza, D; Murillo, O; Ribera, A; Tubau, F | 1 |
| Andréjak, C; Chabot, F; Godbert, B; Hermann, J; Huet, D; Zordan, JM | 1 |
| Bi, Y; El-Kattan, AF; Eng, H; Kalgutkar, AS; Kimoto, E; Lin, J; Rodrigues, AD; Scialis, R; Tremaine, LM; Varma, MV | 1 |
| Aubry, A; Chauffour, A; Jarlier, V; Robert, J; Veziris, N | 1 |
| Fernandes, SE; Laurenson, IF; Noble, DD; Velu, PP | 1 |
| Albert, A; Patel, H; Santos, MA | 1 |
| Lesic, AR; Pesut, DP; Stevic, RS; Stjepanovic, MI | 1 |
| Giguère, S | 1 |
| Burrow, JA; MacKAY, RJ; Mallicote, MF; Muniz, AL; Sanchez, LC; Stieler Stewart, AL; Westerterp, MS | 1 |
| Kadota, JI; Kurashima, A; Suzuki, K | 1 |
| Furuta, S; Furuya, H; Hirose, K; Ikeda, K; Miyachi, K; Nakajima, H; Nakamura, K; Sakagami, T; Suzuki, K; Tamachi, T | 1 |
| Curtis, N; Freyne, B | 1 |
| Fyfe, JA; Globan, M; Malik, R; McCowan, C; O'Brien, CR; Reppas, G | 1 |
| Fremlin, GA; Kaur, MR; Orpin, S | 1 |
| Ikeuchi, T; Kakite, S; Nakamatsu, S; Nakazaki, H; Takemoto, Y; Tokuyasu, H; Yamasaki, K | 1 |
| Bessudo, A; Esseltine, DL; Gupta, N; Hanley, MJ; Ke, A; Liu, G; Nemunaitis, J; O'Neil, BH; Patel, C; Rasco, DW; Rowland Yeo, K; Sharma, S; Venkatakrishnan, K; Wang, B; Xia, C; Zhang, X | 1 |
| Costa, S; Gonçalves, R; Soares, JB | 1 |
| Arar, D; Barisic, I; Goic-Barisic, I; Katalinic-Jankovic, V; Makek, MJ; Novak, A; Peric, I; Popovic, DR; Popovic, V; Rubic, Z; Tonkic, M | 1 |
| Daali, Y; Desmeules, JA; Marsousi, N; Rudaz, S | 1 |
| Berghaus, LJ; Giguère, S; Willingham-Lane, JM | 1 |
| Inagaki, Y; Ito, T; Kato, T; Ono, Y; Sawa, M | 1 |
| Huang, E; Meeker, DG; Moon, SH; Smeltzer, MS; Zhang, X; Zheng, G | 1 |
| Addo, KK; Addo, SO; Bonsu, FA; Mensah, GI; Mosi, L | 1 |
| Guarner, J | 1 |
| Elsner, P; Kranzer, K; Rässler, F; Schliemann, S; Tittelbach, J; Zollmann, C | 1 |
| Andersen, AB; Holden, IK; Johansen, IS; Kehrer, M; Svensson, E; Wejse, C | 1 |
| Huang, E; Moon, SH | 1 |
| Aarnoutse, RE; Brouwer, MAE; Ferro, BE; Jenniskens, JCA; Mouton, JW; Schoutrop, ELM; van Ingen, J | 1 |
| Britz, H; Eissing, T; Frechen, S; Hanke, N; Lehr, T; Moj, D; Wendl, T | 1 |
| Ishii, N; Richardson, M; Yotsu, RR | 1 |
| Astari, L; Cambau, E; do Nascimento, DC; Gillini, L; Grosset, J; Izumi, S; Kar, HK; Mieras, LF; Prakoeswa, CRS; Saunderson, PR; Scollard, DM; Smith, WCS; Sturkenboom, MGG; Taal, AT; van Brakel, WH; Virmond, MCL | 1 |
| Barr, BS; Carter, CN; Cohen, ND; Elam, J; Erol, E; Giguère, S; Huber, L; Locke, SJ; Phillips, ED; Slovis, NM; Smith, JL | 1 |
| Acharya, N; Chattopadhyay, A; Sharma, A; Sharma, K | 1 |
| Funaishi, K; Hattori, N; Ishiyama, S; Kawamoto, K; Matsumoto, N; Matsumoto, Y; Ohashi, N; Saito, N; Sakamoto, KI; Taniwaki, M; Yamasaki, M | 1 |
| Biscontini, G; De Lorenzi, G; Kamphuisen, K; Luppi, A; Pacciarini, M; Zanoni, M | 1 |
| Almeida, DV; Converse, PJ; Grosset, JH; Lee, J; Li, SY; Nuermberger, EL; Omansen, TF | 1 |
| Arenaz-Callao, MP; González Del Río, R; Lucía Quintana, A; Mendoza-Losana, A; Ramón-García, S; Thompson, CJ | 1 |
| Li, QF; Li, YJ; Liao, Y; Luo, J; Wang, DM; Wu, GH; Xu, YH; Zhong, J; Zhu, M | 1 |
| Azevedo, F; Esteves, M; Nogueira, A | 1 |
| Almeida, DV; Converse, PJ; Nuermberger, EL; Tyagi, S; Xu, J | 1 |
| Baladi, B; Brehin, C; Calmels, MN; Cogo, H; Debuisson, C; Gallois, Y; Guet-Revillet, H | 1 |
| Aivaz, O; Kimes, K; Marchalik, R; Norton, SA | 1 |
| Hashimoto, H; Inoue, Y; Kogure, Y; Nakagawa, T; Ogawa, K; Saito, AM; Sekimizu, M; Yagi, M | 1 |
| Abass, MK; Adu, E; Agbavor, B; Ahor, H; Amoako, YA; Asiedu, K; Awuah, DO; Boakye-Yiadom, E; Danso, KG; Frimpong, M; Phillips, RO; Plange-Rhule, G; Sarpong, F; Wansbrough-Jones, M | 1 |
| Hagiya, H; Hamada, K; Hamaguchi, S; Hori, Y; Morii, E; Okuno, H; Tanaka, H; Tomono, K; Yoshida, H; Yoshikawa, H | 1 |
| Huang, E; Kaufmann, Y; Moon, SH | 1 |
| Dickinson, GL; Hall, SD; Kulanthaivel, P; Morse, BL; Posada, MM; Turner, PK | 1 |
| Johnson, PDR | 1 |
| Abass, KM; Agossadou, D; Ampadu, EO; Asiedu, KB; Chauty, A; Egondi, TW; Frimpong, M; Ganlonon, L; Gateau, T; Grosset, J; Lehman, L; Macdonald, JM; Marion, E; Ochieng Otieno, M; Ohene, SA; Omollo, R; Paintsil, A; Phillips, RO; Robert, J; Saizonou, R; Sarfo, FS; Sarpong, G; Sarpong, NF; Saunderson, P; Stienstra, Y; Thompson, W; Tiendrebeogo, A; Treadwell, T; van der Werf, TS; Wansbrough-Jones, M; Wilson, T | 1 |
| Adachi, Y; Hayashi, S; Kagawa, T; Kobayashi, T; Kurahara, Y; Suzuki, K; Tsuyuguchi, K; Yoshida, S | 1 |
| Fujita, K; Hayakawa, H; Ito, Y; Iwaizumi, E; Kanai, M; Kojima, S; Miwa, S; Ohba, H; Oshima, T; Shirai, M; Suda, T | 1 |
| Jerjen, R; Moodley, A; Sinclair, R | 1 |
| Battegay, M; Courlet, P; Decosterd, LA; Kinvig, H; Marzolini, C; Penny, MA; Siccardi, M; Stader, F | 1 |
| Adams, LB; Collins, JH; Hagge, DA; Lahiri, R; Lenz, SM; Ray, NA | 1 |
| Eder, IB; Kunz, M; Simon, JC; Zimmerlich, S | 1 |
| Hosoda, C; Ishiguro, T; Kanegane, H; Shimizu, Y; Takayanagi, N | 1 |
| Alix, C; Bénéjat, L; Bessède, E; Charron, P; Ducournau, A; Lehours, P; Mégraud, F | 1 |
| Arya, R; Cheon, DH; Choi, Y; Chong, YP; Choo, S; Hyun, S; Jin, SM; Jo, D; Kim, KK; Kim, S; Kim, YS; Lee, S; Lee, Y; Park, S; Park, SJ; Park, TW; Yoo, W; Yu, J | 1 |
| Chaturvedula, A; Cicali, B; Cristofoletti, R; Hoechel, J; Lingineni, K; Schmidt, S; Vozmediano, V; Wendl, T; Wiesinger, H | 1 |
| Damanhuri, NS; Kumolosasi, E; Mansor, AH; Omar, MS; Razak, AFA | 1 |
| Abay, S; Akar, M; Aydın, F; Karakaya, E; Kayman, T | 1 |
| Khandelwal, S; Malhotra, B; Sharma, M | 1 |
| Kaji, Y; Nakamura, O; Nomura, Y; Oka, K; Yamaguchi, K; Yamamoto, T | 1 |
| Ando, T; Kage, H; Matsumoto, Y; Nagase, T; Zokumasu, K | 1 |
| Pluschke, G; Warryn, L | 1 |
| Enoki, Y; Hasegawa, N; Iketani, O; Kizu, J; Komeya, A; Matsumoto, K; Taguchi, K; Uno, S; Uwamino, Y | 1 |
| Akrami, S; Dokht Khosravi, A; Hashemzadeh, M | 1 |
| Abdrabou, AMM; Berger, FK; Bischoff, M; Gärtner, BC; Margardt, L; Mellmann, A; von Müller, L | 1 |
| Abouwarda, AM; Abu El-Wafa, WM; Faraag, AHI; Ismail, TA | 1 |
| Huang, H; Jiang, G; Li, H; Liao, X; Sun, Q; Wang, C; Wang, G; Yang, J; Zhao, J | 1 |
| Enoki, Y; Fukunaga, K; Hasegawa, N; Kizu, J; Matsumoto, K; Namkoong, H; Ozawa, T; Taguchi, K; Takahashi, Y; Takaya, R | 1 |
| Addo, J; Anagonou, ES; Ayelo, AG; Biswas, N; Calderon, F; Cruz, I; Della Pasqua, O; Díez, G; Gine-March, A; Gnimavo, RS; Herrador, Z; Houezo, JG; Johnson, RC; Kpoton, GG; Mendoza-Losana, A; Mignanwande, FZ; Orford, L; Ramón-García, S; Sáez-López, E; Sopoh, GE; Vlasakakis, G | 1 |
| Coco, M; Cucuzza, ME; Di Stefano, VA; Garozzo, MT | 1 |
| Lin, Y; Miao, M; Shao, Y; Wang, B; Ye, G | 1 |
| Chamseddine, S; Haddad, SF; Hindy, JR; Kanj, SS | 1 |
| Benghezal, M; Li, H; Marshall, BJ; Shen, Y; Song, X; Tang, H; Tang, X; Wang, Z | 1 |
| Barth, SA; Häußler, TC; Köhler, K; Prenger-Berninghoff, E; Thom, N | 1 |
| Agay-Shay, K; Azrad, M; On, A; Paritski, M; Peretz, A; Rohana, H; Roshrosh, H; Vazana, D | 1 |
| Garg, S; Kumar, R; Kunimoto, D; Rayat, GR | 1 |
| A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
| Chen, H; Guo, Y; Lv, H; Xu, JZ; Zhang, ZH; Zhang, ZR; Zhou, JH | 1 |
| Benghezal, M; Li, H; Marshall, BJ; Shen, Y; Song, X; Tang, H; Tang, X; Yang, T | 1 |
24 review(s) available for clarithromycin and rifampin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Treatment of Legionnaires' disease. Current recommendations.
Topics: Administration, Oral; Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Drug Tolerance; Erythromycin; Humans; Infusions, Parenteral; Legionnaires' Disease; Rifampin | 1993 |
Pulmonary infection due to Mycobacterium xenopi.
Topics: Bacterial Typing Techniques; Clarithromycin; Cycloserine; DNA Probes; Drug Resistance, Microbial; Gastrectomy; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium Infections; Respiratory Tract Infections; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1994 |
[Present status of studies on antileprosy drugs].
Topics: Animals; Clarithromycin; Dapsone; Drug Therapy, Combination; Humans; Immunologic Factors; Leprostatic Agents; Minocycline; Prothionamide; Quinolones; Rifampin; Rifamycins; Thalidomide | 1995 |
[A case of arthritis of the wrist caused by Mycobacterium marinum. Review of the literature].
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Arthritis, Infectious; Ciprofloxacin; Clarithromycin; Debridement; Drug Therapy, Combination; Female; Humans; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Wrist Joint | 1996 |
Facial sporotrichoid infection with Mycobacterium marinum.
Topics: Administration, Oral; Anti-Bacterial Agents; Child, Preschool; Chronic Disease; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Facial Dermatoses; Humans; Male; Mycobacterium Infections, Nontuberculous; Rifampin; Sporotrichosis | 1997 |
A hoarse voice: atypical mycobacterial infection of the larynx.
Topics: Aged; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Hoarseness; Humans; Isoniazid; Laryngeal Diseases; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pyridoxine; Rifampin; Sputum; Staining and Labeling | 2001 |
[Nontuberculous mycobacteriosis].
Topics: Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Pneumonia, Bacterial; Prognosis; Rifampin; Streptomycin | 2003 |
Mycobacterium malmoense infection of the knee.
Topics: Azithromycin; Clarithromycin; Drug Therapy, Combination; Female; Humans; Knee Joint; Magnetic Resonance Imaging; Middle Aged; Mycobacterium Infections, Nontuberculous; Myositis; Nontuberculous Mycobacteria; Popliteal Cyst; Rifampin | 2003 |
[Nontuberculous mycobacteria in cystic fibrosis].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Child; Clarithromycin; Cystic Fibrosis; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin | 2005 |
[Anti-retroviral treatment in patients with AIDS and mycobacterial diseases].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Retroviral Agents; Clarithromycin; Drug Interactions; Humans; Mycobacterium Infections; Rifampin; Tuberculosis | 2005 |
[Diagnosis and therapy of Rhodococcus equi infection in the horse].
Topics: Actinomycetales Infections; Animals; Animals, Newborn; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Therapy, Combination; Erythromycin; Horse Diseases; Horses; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Treatment Outcome | 2006 |
Mycobacterium marinum infection: a case report and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Ethambutol; Forearm; Hand Dermatoses; Humans; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifampin; Skin Diseases, Bacterial | 2007 |
[Perspective of pulmonary MAC infection treatment].
Topics: Aminoglycosides; Antitubercular Agents; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Ethambutol; Evidence-Based Medicine; Humans; Mycobacterium avium-intracellulare Infection; Practice Guidelines as Topic; Rifampin; Secondary Prevention; Time Factors; Tuberculosis, Pulmonary | 2007 |
Disseminated Mycobacterium kansasii infection associated with skin lesions: a case report and comprehensive review of the literature.
Topics: Antitubercular Agents; Clarithromycin; Glucocorticoids; Humans; Immunocompromised Host; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Myelodysplastic Syndromes; Rifampin; Skin Diseases, Bacterial; Sputum; Sweet Syndrome | 2010 |
Anti-tuberculous therapy for maintenance of remission in Crohn's disease.
Topics: Antitubercular Agents; Clarithromycin; Clofazimine; Crohn Disease; Ethambutol; Glucocorticoids; Humans; Maintenance Chemotherapy; Methylprednisolone; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Rifabutin; Rifampin; Secondary Prevention | 2016 |
Treatment of Infections Caused by Rhodococcus equi.
Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Horse Diseases; Horses; Pneumonia, Bacterial; Rhodococcus equi; Rifampin | 2017 |
Antimicrobial Resistance in
Topics: Animal Diseases; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Combinations; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Horses; Lincosamides; Macrolides; Microbial Sensitivity Tests; Rhodococcus equi; Rifampin; Streptogramin B | 2017 |
Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease.
Topics: Africa, Western; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Humans; Macrolides; Mycobacterium Infections; Mycobacterium ulcerans; Neglected Diseases; Polymerase Chain Reaction; Rifampin; Skin Diseases, Bacterial; Streptomycin | 2018 |
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).
Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Clofazimine; Drug Therapy, Combination; Humans; Mycobacterium ulcerans; Observational Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Clinical Data Combined With Modeling and Simulation Indicate Unchanged Drug-Drug Interaction Magnitudes in the Elderly.
Topics: Adult; Aged; Aged, 80 and over; Aging; Clarithromycin; Cohort Studies; Comorbidity; Computer Simulation; Drug Interactions; Female; Humans; Male; Midazolam; Middle Aged; Models, Biological; Polypharmacy; Prospective Studies; Rifampin; Young Adult | 2021 |
Combined administration of rifampicin, ethambutol, and clarithromycin for the treatment of tenosynovitis of the hand caused by Mycobacterium avium complex: Case series and literature review.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Hand; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Tenosynovitis | 2021 |
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Mycobacterium Avium Complex Infection of the Spine in a Patient Without Acquired Immune Deficiency Syndrome: A Case Report and Literature Review.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Humans; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 2023 |
31 trial(s) available for clarithromycin and rifampin
| Article | Year |
|---|---|
Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Clarithromycin; Colony Count, Microbial; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 1991 |
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Protein Synthesis Inhibitors; Rifabutin; Rifampin; Streptomycin; Treatment Outcome | 1996 |
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Survival Analysis; Treatment Outcome; Uveitis | 1996 |
[Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Kanamycin; Mycobacterium avium-intracellulare Infection; Ofloxacin; Pilot Projects; Rifampin; Tuberculosis, Pulmonary | 1996 |
Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Ethambutol; Female; Fluoroquinolones; Humans; Kanamycin; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Survival Analysis; Treatment Outcome | 1999 |
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Bacteremia; Canada; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Health Status; Humans; Mycobacterium avium-intracellulare Infection; Outcome and Process Assessment, Health Care; Rifabutin; Rifampin; Treatment Outcome | 2000 |
[A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Streptomycin; Time Factors; Treatment Outcome | 2000 |
Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Leukopenia; Male; Minocycline; Recurrence; Rifampin | 2000 |
Researchers find new drugs to fight MAC.
Topics: AIDS-Related Opportunistic Infections; Animals; Antitubercular Agents; CD4 Lymphocyte Count; Clarithromycin; Half-Life; Humans; Mycobacterium avium-intracellulare Infection; Placebos; Randomized Controlled Trials as Topic; Rifabutin; Rifampin | 1995 |
[Roxithromycin therapy of patients with mycobacterium avium complex lung infection].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin; Roxithromycin; Treatment Outcome; Tuberculosis, Pulmonary | 2001 |
The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Practice Guidelines as Topic; Prospective Studies; Rifampin; Streptomycin; Treatment Outcome | 2003 |
Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans.
Topics: Administration, Oral; Adult; Area Under Curve; Cimicifuga; Clarithromycin; Dietary Supplements; Digoxin; Drug Administration Schedule; Female; Genes, MDR; Half-Life; Haplotypes; Herb-Drug Interactions; Humans; Male; Plant Preparations; Rifampin; Silybum marianum | 2006 |
Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin.
Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Area Under Curve; Cimicifuga; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dietary Supplements; Drug Interactions; Enzyme Activators; Enzyme Inhibitors; Female; Humans; Hypnotics and Sedatives; Male; Midazolam; Phenotype; Rifampin; Sex Characteristics; Silybum marianum | 2006 |
Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease.
Topics: Aged; Antitubercular Agents; Bronchiectasis; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Ethambutol; Female; Forced Expiratory Flow Rates; Forced Expiratory Volume; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Radiography; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2006 |
Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans.
Topics: Adult; Cardiotonic Agents; Clarithromycin; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Digoxin; Drug Interactions; Female; Herb-Drug Interactions; Humans; Hydrastis; Kava; Male; Rifampin | 2007 |
Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo.
Topics: Adult; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dietary Supplements; Enzyme Induction; Enzyme Inhibitors; Female; Herb-Drug Interactions; Humans; Hydrastis; Kava; Male; Midazolam; Models, Biological; Phenotype; Plant Preparations; Rifampin; Risk Assessment; Substrate Specificity | 2008 |
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunotherapy; Male; Middle Aged; Opportunistic Infections; Rifampin; Tuberculosis, Pulmonary | 2008 |
Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.
Topics: Aged; Anti-Bacterial Agents; Blood Sedimentation; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Radiography; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2008 |
Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Buruli Ulcer; Child; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Endpoint Determination; Female; Follow-Up Studies; Ghana; Humans; Injections, Intramuscular; Leprostatic Agents; Male; Mycobacterium ulcerans; Rifampin; Statistics, Nonparametric; Streptomycin; Time Factors; Treatment Outcome; Young Adult | 2010 |
Pharmacokinetics of rifampin and clarithromycin in patients treated for Mycobacterium ulcerans infection.
Topics: Antibiotics, Antitubercular; Buruli Ulcer; Chromatography, Liquid; Clarithromycin; Humans; Microbial Sensitivity Tests; Rifampin; Tandem Mass Spectrometry | 2010 |
LC-MS/MS method for the simultaneous determination of clarithromycin, rifampicin and their main metabolites in horse plasma, epithelial lining fluid and broncho-alveolar cells.
Topics: Animals; Anti-Bacterial Agents; Biotransformation; Bronchioles; Bronchoalveolar Lavage Fluid; Chromatography, High Pressure Liquid; Clarithromycin; Drug Interactions; Drug Stability; Horse Diseases; Horses; Limit of Detection; Pulmonary Alveoli; Reproducibility of Results; Respiratory Tract Infections; Rifampin; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2011 |
A randomised controlled trial assessing the effect of adding clarithromycin to rifampicin, ofloxacin and minocycline in the treatment of single lesion paucibacillary leprosy in Agra District, India.
Topics: Adolescent; Adult; Child; Child, Preschool; Clarithromycin; Female; Humans; India; Leprosy, Paucibacillary; Male; Middle Aged; Minocycline; Ofloxacin; Recurrence; Rifampin; Survival Analysis; Treatment Outcome | 2011 |
The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease.
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Treatment Outcome | 2012 |
Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2014 |
Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Azithromycin; Clarithromycin; Comorbidity; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Logistic Models; Macrolides; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Outcome and Process Assessment, Health Care; Practice Guidelines as Topic; Republic of Korea; Retrospective Studies; Rifampin; Sputum | 2015 |
Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug-Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic Ana
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Boron Compounds; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Glycine; Humans; Ketoconazole; Male; Middle Aged; Models, Biological; Neoplasms; Proteasome Inhibitors; Rifampin | 2018 |
Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic
Topics: Adult; Aged; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Japan; Male; Middle Aged; Multicenter Studies as Topic; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quality of Life; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome; Young Adult | 2019 |
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benin; Buruli Ulcer; Child; Clarithromycin; Delayed-Action Preparations; Drug Therapy, Combination; Female; Ghana; Humans; Male; Rifampin; Streptomycin; Wound Healing; Young Adult | 2020 |
Lower dose of ethambutol may reduce ocular toxicity without radiological deterioration for Mycobacterium avium complex pulmonary disease.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Lung Diseases; Macrolides; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Toxic Optic Neuropathy | 2021 |
Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled mu
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Benin; Buruli Ulcer; Clarithromycin; Clinical Trials, Phase II as Topic; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome | 2022 |
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
294 other study(ies) available for clarithromycin and rifampin
| Article | Year |
|---|---|
Design and studies of novel 5-substituted alkynylpyrimidine nucleosides as potent inhibitors of mycobacteria.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Chlorocebus aethiops; Drug Design; Humans; Mycobacterium avium; Mycobacterium bovis; Pyrimidine Nucleosides; Structure-Activity Relationship | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Studies on acyclic pyrimidines as inhibitors of mycobacteria.
Topics: Anti-Bacterial Agents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium; Pyrimidines; Species Specificity | 2007 |
Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
Topics: Animals; Arabinofuranosyluracil; Cell Line; Cell Survival; Chlorocebus aethiops; Drug Resistance, Bacterial; Floxuridine; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Pyrimidine Nucleosides; Rifampin; Structure-Activity Relationship | 2007 |
Orally administered combined regimens for treatment of Mycobacterium ulcerans infection in mice.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Aza Compounds; Clarithromycin; Colony Count, Microbial; Drug Combinations; Female; Fluoroquinolones; Foot; Mice; Mice, Inbred BALB C; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Quinolines; Rifampin; Streptomycin | 2007 |
Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
Topics: Adenosine; Alkynes; Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dideoxynucleosides; Drug Resistance, Bacterial; Guanosine; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Purine Nucleosides; Structure-Activity Relationship; Uridine | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cells, Cultured; Colon; Crohn Disease; Culture Media; Escherichia coli; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Monocytes; Mucous Membrane | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Cricetinae; Fibroblasts; Gram-Negative Bacteria; Kidney Cortex; Lung; Microbial Sensitivity Tests; Microvilli; Polymyxin B; Rats; Structure-Activity Relationship | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
Topics: Anti-Bacterial Agents; China; Cities; Drug Resistance, Multiple, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
Topics: Anti-Bacterial Agents; Erythromycin; Luminescent Proteins; Microbial Sensitivity Tests; Models, Genetic; Mycobacterium ulcerans; Reserpine; Tetracycline | 2010 |
A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane.
Topics: Animals; Anti-Bacterial Agents; Cell Membrane Permeability; Cricetinae; Cricetulus; Drug Synergism; Fibroblasts; Gram-Negative Bacteria; Guinea Pigs; Lung; Male; Microbial Sensitivity Tests; Polymyxin B; Rats; Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Minocycline; Neisseria meningitidis; Penicillins; Rifampin; Sulfamethoxazole; Triazoles; Trimethoprim | 2010 |
Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.
Topics: Anti-Bacterial Agents; Aza Compounds; Biofilms; Clarithromycin; Daptomycin; Fluoroquinolones; Microscopy, Electron, Scanning; Moxifloxacin; Quinolines; Rifampin; Staphylococcus aureus; Vancomycin | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Antimycobacterial activities of 5-alkyl (or halo)-3'-substituted pyrimidine nucleoside analogs.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Pyrimidine Nucleosides; Stereoisomerism; Structure-Activity Relationship | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
Topics: Antitubercular Agents; Cell Line, Tumor; Cell Survival; Drug Resistance, Bacterial; Humans; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Pentoxyl; Pyrimidine Nucleosides; Uracil | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Synthesis of novel isothiazolopyridines and their in vitro evaluation against Mycobacterium and Propionibacterium acnes.
Topics: Animals; Antitubercular Agents; Cell Survival; Chlorocebus aethiops; Crystallography, X-Ray; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium; Mycobacterium tuberculosis; Propionibacterium acnes; Pyridines; Structure-Activity Relationship; Thiazoles; Vero Cells | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Investigation of 4-amino-5-alkynylpyrimidine-2(1H)-ones as anti-mycobacterial agents.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Female; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium bovis; Mycobacterium tuberculosis; Pyrimidinones; Structure-Activity Relationship; Tuberculosis | 2016 |
Investigation of C-5 alkynyl (alkynyloxy or hydroxymethyl) and/or N-3 propynyl substituted pyrimidine nucleoside analogs as a new class of antimicrobial agents.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cell Line; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium Infections; Nucleosides; Pyrimidines; Structure-Activity Relationship | 2016 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Opportunities and Limitations for Assigning Relative Configurations of Antibacterial Bislactones using GIAO NMR Shift Calculations.
Topics: Anti-Bacterial Agents; Biological Products; Fungi; Lactones; Magnetic Resonance Spectroscopy; Molecular Structure; Phylogeny; Stereoisomerism | 2021 |
Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens.
Topics: Anaerobiosis; DNA-Directed RNA Polymerases; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Rifamycins | 2022 |
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice.
Topics: Amikacin; Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred C57BL; Mycobacterium avium; Mycobacterium avium Complex; Quinolones; Rifabutin; Rifampin; Rifamycins; Time Factors; Tuberculosis | 1992 |
Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
Topics: Animals; Clarithromycin; Disease Models, Animal; Female; Fluoroquinolones; Foot; Hindlimb; Immunocompetence; Leprostatic Agents; Leprosy; Mice; Microbial Sensitivity Tests; Minocycline; Mycobacterium leprae; Ofloxacin; Quinolones; Rifampin | 1992 |
TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice.
Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Culture Media; Drug Therapy, Combination; Erythromycin; Ethambutol; Gentamicins; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Tuberculosis | 1992 |
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages.
Topics: 4-Quinolones; Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Azithromycin; Cell Division; Clarithromycin; Erythromycin; Fluoroquinolones; Humans; In Vitro Techniques; Leprostatic Agents; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Quinolones; Rifampin | 1991 |
Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex.
Topics: Cell Division; Cells, Cultured; Clarithromycin; Drug Combinations; Erythromycin; Ethambutol; Microbial Sensitivity Tests; Microscopy, Electron; Mycobacterium avium; Rifampin | 1991 |
Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice.
Topics: Animals; Clarithromycin; Drug Therapy, Combination; Erythromycin; Leprosy; Mice; Minocycline; Mycobacterium leprae; Rifampin | 1991 |
Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Enoxacin; Erythromycin; Imipenem; Legionella; Leucomycins; Microbial Sensitivity Tests; Rifampin | 1989 |
An in-vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agent.
Topics: Adult; Amoxicillin; Clarithromycin; Colony Count, Microbial; Erythromycin; Humans; In Vitro Techniques; Listeria; Listeria monocytogenes; Microbial Sensitivity Tests; Neutrophils; Phagocytosis; Rifampin; Staphylococcus aureus | 1988 |
Treatment of Mycobacterium marinum facial abscess using clarithromycin.
Topics: Abscess; Anti-Bacterial Agents; Antibiotics, Antitubercular; Child, Preschool; Clarithromycin; Combined Modality Therapy; Drainage; Drug Therapy, Combination; Face; Female; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Soft Tissue Infections; Tuberculin Test | 1995 |
Activity of combinations of dapsone, rifampin, minocycline, clarithromycin, and sparfloxacin against M. leprae-infected mice.
Topics: Animals; Anti-Infective Agents; Clarithromycin; Dapsone; Drug Therapy, Combination; Female; Fluoroquinolones; Leprosy; Mice; Mice, Inbred BALB C; Minocycline; Quinolones; Rifampin | 1995 |
Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Bacteremia; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; HIV Infections; Humans; Imipenem; Male; Pleurisy; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Sputum; Teicoplanin; Vancomycin | 1994 |
[Legionella pneumonia diagnosed by urinary antigen detection].
Topics: Antigens, Bacterial; Clarithromycin; Drug Therapy, Combination; Humans; Legionella pneumophila; Legionnaires' Disease; Male; Methylprednisolone; Middle Aged; Rifampin | 1995 |
[Rhodococcus equi pneumonia in patients with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Actinomycetales Infections; Adult; Clarithromycin; Erythromycin; Humans; Imipenem; Male; Middle Aged; Pneumonia; Rhodococcus equi; Rifampin; Vancomycin | 1994 |
Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection.
Topics: Clarithromycin; Drug Interactions; Drug Therapy, Combination; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin | 1995 |
Treatment of Mycobacterium haemophilum infection with an antibiotic regimen including clarithromycin.
Topics: Aged; Arthritis, Rheumatoid; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Humans; Male; Mycobacterium Infections, Nontuberculous; Prednisone; Rifampin; Skin; Vasculitis | 1994 |
Intermittent azithromycin for treatment of Mycobacterium avium infection in beige mice.
Topics: Animals; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Tuberculosis | 1994 |
[Ciprofloxacin, clarithromycin, rifampin: in vitro bactericidal activity of double and triple drug combinations against strains of atypical mycobacteria].
Topics: Ciprofloxacin; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; In Vitro Techniques; Mycobacterium phlei; Nontuberculous Mycobacteria; Rifampin | 1993 |
Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
Topics: Administration, Oral; Animals; Clarithromycin; Dapsone; Drug Interactions; Drug Resistance, Microbial; Female; Leprosy; Mice; Mycobacterium leprae; Rifampin | 1993 |
Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium; Rifabutin; Rifampin; Rifamycins | 1993 |
A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Male; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Rifampin; Skin Diseases, Bacterial | 1993 |
Antituberculosis activity of clarithromycin.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Synergism; Female; Isoniazid; Macrophages; Male; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1995 |
Mycobacterium avium-intracellulare complex pneumonia in a non-HIV-infected individual: an increasingly recognized disease.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; HIV Seronegativity; Humans; Male; Mycobacterium avium-intracellulare Infection; Necrosis; Pneumonia, Bacterial; Pulmonary Atelectasis; Rifampin | 1996 |
Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Colony Count, Microbial; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Leprostatic Agents; Leprosy; Mice; Mice, Nude; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin | 1996 |
Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Kanamycin; Lung; Male; Mice; Mycobacterium avium Complex; Rifampin; Rifamycins; Spleen; Tuberculosis | 1996 |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Nontuberculous Mycobacteria; Practice Guidelines as Topic; Pyrazinamide; Pyridoxine; Radiography; Rifabutin; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Experimental evaluation of possible new short-term drug regimens for treatment of multibacillary leprosy.
Topics: Animals; Clarithromycin; Drug Therapy, Combination; Leprostatic Agents; Leprosy; Mice; Mice, Nude; Mycobacterium leprae; Ofloxacin; Rifampin | 1997 |
Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Diagnostic Errors; Drug Therapy, Combination; Humans; Mycobacterium Infections; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin | 1997 |
Osteomyelitis due to Mycobacterium haemophilum in a cardiac transplant patient: case report and analysis of interactions among clarithromycin, rifampin, and cyclosporine.
Topics: Adult; Clarithromycin; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Mycobacterium haemophilum; Mycobacterium Infections; Osteomyelitis; Rifampin | 1997 |
Flexor tenosynovitis in the hand caused by Mycobacterium malmoense: a case report.
Topics: Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Ethambutol; Fingers; Follow-Up Studies; Humans; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Synovectomy; Tenosynovitis | 1997 |
Evaluation of the post-antibiotic effect of six anti-mycobacterial agents against Mycobacterium avium by the Bactec radiometric method.
Topics: Amikacin; Antitubercular Agents; Cell Division; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium; Radiometry; Rifampin | 1997 |
Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cells, Cultured; Clarithromycin; Drug Synergism; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 1997 |
[Pneumonia caused by Rhodococcus equi in patients with AIDS: difficulty in defining the most appropriate initial treatment].
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Erythromycin; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin | 1997 |
A retrospective comparison of clarithromycin versus rifampin in combination treatment for disseminated Mycobacterium avium complex disease in AIDS: clarithromycin decreases transfusion requirements.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteremia; Blood Transfusion; Clarithromycin; Colorado; Community Health Centers; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Survival Rate; Treatment Outcome | 1997 |
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine).
Topics: Anti-Bacterial Agents; Azithromycin; Bordetella; Bordetella pertussis; Clarithromycin; Erythromycin; Ketolides; Macrolides; Microbial Sensitivity Tests; Rifabutin; Rifampin; Roxithromycin | 1998 |
Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium.
Topics: Amikacin; Anti-Bacterial Agents; Bacteriological Techniques; Clarithromycin; Clofazimine; Colony Count, Microbial; Fluoroquinolones; Humans; Mycobacterium avium Complex; Quinolones; Rifampin; Serum Bactericidal Test | 1997 |
Pulsed-exposure and postantibiotic leukocyte enhancement effects of amikacin, clarithromycin, clofazimine, and rifampin against intracellular Mycobacterium avium.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Humans; Leukocytes; Macrophages; Mycobacterium avium; Phagocytosis; Rifampin | 1998 |
Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium tuberculosis.
Topics: Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Fleroxacin; Fusidic Acid; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1995 |
Postantibiotic effects of rifampin, amikacin, clarithromycin and ethambutol used alone or in various two-, three- and four-drug combinations against Mycobacterium avium.
Topics: AIDS-Related Opportunistic Infections; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiometry; Rifampin | 1999 |
Therapeutic dilemma: crescentic mesangiocapillary glomerulonephritis type 1 in a patient on antituberculous therapy with rifampicin.
Topics: Aged; Antitubercular Agents; Clarithromycin; Female; Glomerulonephritis, Membranoproliferative; Humans; Isoniazid; Methylprednisolone; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Tuberculosis, Pulmonary | 1999 |
Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Azithromycin; Biological Availability; Clarithromycin; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Nafcillin; Osteomyelitis; Rabbits; Rifampin; Staphylococcal Infections; Tibia; Treatment Outcome | 1999 |
Atypical mycobacterium infection with dermatological manifestation in a renal transplant recipient.
Topics: Clarithromycin; Drug Therapy, Combination; Ethambutol; Foot; Humans; Kidney Transplantation; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Postoperative Complications; Rifampin; Skin Diseases, Bacterial | 1999 |
In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Gatifloxacin; Legionella; Microbial Sensitivity Tests; Rifampin | 1999 |
Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease.
Topics: Adolescent; Adult; Antitubercular Agents; Biological Availability; Clarithromycin; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Mycobacterium avium-intracellulare Infection; Pregnancy; Rifampin; Tuberculosis, Pulmonary | 1999 |
Chronic pneumonia caused by Mycobacterium thermoresistibile in a cat.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Chronic Disease; Clarithromycin; Doxycycline; Female; Mycobacterium; Pneumonia; Rifampin | 1999 |
[Sporotrichoid mycobacteriosis caused by Mycobacterium marinum].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Bacteriological Techniques; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifampin; Skin Diseases, Bacterial; Sporotrichosis | 1999 |
Mycobacterium avium infection of the skin associated with lichen scrofulosorum: report of three cases.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Child; Child, Preschool; Clarithromycin; DNA, Bacterial; Humans; In Situ Hybridization; Isoniazid; Lichenoid Eruptions; Male; Mycobacterium avium Complex; Polymerase Chain Reaction; Rifampin; Thorax; Tuberculosis, Cutaneous | 1999 |
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.
Topics: Adult; Africa; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Cloxacillin; Ethambutol; Humans; Leg Ulcer; Male; Metronidazole; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Penicillins; Rifampin; Skin Diseases, Bacterial; Skin Transplantation; Travel; Trimethoprim, Sulfamethoxazole Drug Combination; Virulence | 1999 |
In-vitro activity of moxifloxacin combined with other antibacterials against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Aza Compounds; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rifampin; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2000 |
Interaction of gliclazide and rifampicin.
Topics: Aged; Antibiotics, Antitubercular; Clarithromycin; Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, Combination; Ethambutol; Gliclazide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Isoniazid; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin | 2000 |
[Cutaneous nodular infection with hemopathy].
Topics: Adult; Biopsy; Clarithromycin; Drug Therapy, Combination; Granuloma; Humans; Leukemia, Hairy Cell; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifampin; Skin Diseases, Bacterial | 2000 |
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Interactions; Humans; Imipenem; Methicillin Resistance; Nisin; Peptides, Cyclic; Rana catesbeiana; Rifampin; Staphylococcus aureus; Vancomycin | 2000 |
Mycobacterium genavense infection in two aged ferrets with conjunctival lesions.
Topics: Animals; Clarithromycin; Clofazimine; Conjunctivitis, Bacterial; Diagnosis, Differential; DNA Primers; Drug Therapy, Combination; Fatal Outcome; Female; Ferrets; Male; Mycobacterium; Mycobacterium Infections; Polymerase Chain Reaction; Rifampin; RNA, Bacterial | 2000 |
Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori.
Topics: Anti-Bacterial Agents; Base Sequence; Ciprofloxacin; Clarithromycin; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Microbial; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Rifampin; Transformation, Bacterial | 2001 |
Treatment of canine leproid granuloma syndrome: preliminary findings in seven dogs.
Topics: Animals; Clarithromycin; Dog Diseases; Dogs; Drug Administration Schedule; Drug Therapy, Combination; Female; Leprostatic Agents; Leprosy, Lepromatous; Male; New South Wales; Prospective Studies; Retrospective Studies; Rifampin; Syndrome | 2001 |
Phenotypic consequences of red-white colony type variation in Mycobacterium avium.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Congo Red; Drug Resistance, Microbial; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Phenotype; Pigments, Biological; Rifampin; Virulence | 2001 |
Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Child; Child, Preschool; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Greece; Humans; Infant; Male; Microbial Sensitivity Tests; Oropharynx; Phenotype; Rifampin; Streptococcus; Tetracycline; Vancomycin; Virginiamycin | 2001 |
[Buruli ulcer in Togo: 21 cases].
Topics: Adolescent; Adult; Age Factors; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Clarithromycin; Curettage; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Rifampin; Skin Transplantation; Time Factors; Togo | 2001 |
A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Colony Count, Microbial; Dapsone; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Leprostatic Agents; Leprosy; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mycobacterium leprae; Ofloxacin; Rifampin | 2000 |
Advances in prevention and treatment of MAC.
Topics: AIDS-Related Opportunistic Infections; Azithromycin; CD4 Lymphocyte Count; Clarithromycin; Clinical Trials as Topic; Clofazimine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin | 1995 |
CPCRA researchers present OI studies at Vancouver.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antitubercular Agents; Candidiasis; Child; Clarithromycin; Clinical Trials as Topic; DNA, Viral; Drug Therapy, Combination; Ethambutol; Female; Fluconazole; Humans; Isoniazid; Molluscum Contagiosum; Molluscum contagiosum virus; Multicenter Studies as Topic; Mycobacterium avium-intracellulare Infection; Ofloxacin; Patient Compliance; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Tuberculosis | 1996 |
MAC management.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Interactions; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Tuberculin Test; Zidovudine | 1996 |
Rapid identification of cutaneous infections by nontubercular mycobacteria by polymerase chain reaction-restriction analysis length polymorphism of the hsp65 gene.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Chaperonin 60; Chaperonins; Clarithromycin; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Polymerase Chain Reaction; Rifampin; Skin Diseases, Bacterial | 2001 |
[Are the antimicrobials used in community-acquired respiratory infection useful for preventing transmission of meningococcal disease? In vitro study].
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Community-Acquired Infections; Drug Resistance; Fluoroquinolones; Humans; Meningococcal Infections; Microbial Sensitivity Tests; Naphthyridines; Nasopharynx; Neisseria meningitidis; Respiratory Tract Infections; Rifampin; Time Factors | 2001 |
Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori.
Topics: Adenosine Triphosphatases; Animals; Bacterial Proteins; Base Pair Mismatch; Clarithromycin; DNA Repair; DNA-Binding Proteins; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli Proteins; Genes, Bacterial; Helicobacter pylori; Humans; Lewis Blood Group Antigens; Mice; Mice, Transgenic; Models, Biological; Mutation; MutS DNA Mismatch-Binding Protein; Rifampin | 2001 |
Efficacy of macrolides used in combination with ethambutol, with or without other drugs, against Mycobacterium avium within human macrophages.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cells, Cultured; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium; Rifampin | 2001 |
In vitro activity of rifampicin against Helicobacter pylori isolated from children and adults.
Topics: Adolescent; Adult; Amoxicillin; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Rifampin | 2002 |
Feline leprosy: two different clinical syndromes.
Topics: Animals; Cat Diseases; Cats; Clarithromycin; Clofazimine; Female; Leprostatic Agents; Leprosy, Lepromatous; Male; Mycobacterium; Polymerase Chain Reaction; Rifampin; RNA, Ribosomal, 16S | 2002 |
Mycobacterium haemophilum infection in an SLE patient on mycophenolate mofetil.
Topics: Adult; Anti-Bacterial Agents; Antirheumatic Agents; Clarithromycin; Cyclophosphamide; Ethambutol; Female; Humans; Immunosuppressive Agents; Isoniazid; Leg; Lupus Erythematosus, Systemic; Muscle, Skeletal; Mycobacterium haemophilum; Mycobacterium Infections; Mycophenolic Acid; Rifampin | 2002 |
Disseminated Mycobacterium ulcerans disease in an HIV-positive patient: a case study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Polymerase Chain Reaction; Rifampin | 2002 |
Atypical mycobacterial osteomyelitis in a non-AIDS patient.
Topics: Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Middle Aged; Mycobacterium avium-intracellulare Infection; Osteomyelitis; Rifampin; Thoracic Vertebrae | 2002 |
Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Female; Fluoroquinolones; Foot; Mice; Mice, Inbred BALB C; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Rifampin; Skin Ulcer | 2002 |
Nontuberculous mycobacterial infections in pediatric acute leukemia.
Topics: Child, Preschool; Clarithromycin; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rifampin | 2002 |
Co-infection with Esptein-Barr virus and Bartonella henselae resulting in systemic bartonellosis.
Topics: Animals; Bartonella henselae; Cat-Scratch Disease; Cats; Child; Clarithromycin; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunoglobulin G; Immunoglobulin M; Rifampin; Sepsis; Serologic Tests | 2002 |
In vitro sensitivity of Mycobacterium xenopi to five antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Ethambutol; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Ofloxacin; Rifampin | 2002 |
Ocular manifestation of disseminated Mycobacterium simiae infection in a cat.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Bacteremia; Cat Diseases; Cats; Clarithromycin; Diagnosis, Differential; Diagnostic Techniques, Ophthalmological; Drug Therapy, Combination; Enrofloxacin; Fluoroquinolones; Male; Mycobacterium; Mycobacterium Infections; Quinolones; Radiography; Rifampin; Tuberculosis, Ocular | 2003 |
[Effects of antisense oligo DNA on the antimicrobial activity of reactive oxygen intermediates and antimycobacterial agents against Mycobacterium avium complex].
Topics: Clarithromycin; DNA-Binding Proteins; Drug Resistance, Bacterial; Halogens; Hydrogen Peroxide; Mycobacterium avium Complex; Oligodeoxyribonucleotides, Antisense; Repressor Proteins; Rifampin; Transcription Factors; Virulence | 2003 |
Buruli's ulcer: three cases diagnosed and treated in France.
Topics: Anti-Bacterial Agents; Child; Clarithromycin; Cote d'Ivoire; France; Humans; Leg; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Rifampin; Soft Tissue Infections | 2003 |
Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Child; Clarithromycin; Cohort Studies; Cystic Fibrosis; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Retrospective Studies; Rifampin; Streptomycin | 2003 |
Severe reduction in tacrolimus levels with rifampin despite multiple cytochrome P450 inhibitors: a case report.
Topics: Adult; Clarithromycin; Creatinine; Cytochrome P-450 Enzyme Inhibitors; Diltiazem; Drug Interactions; Drug Therapy, Combination; Female; Fluconazole; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Rifampin; Tacrolimus | 2003 |
[Cutaneous infection with Mycobacterium marinum. successful therapy with rifampicin and clarithromycin].
Topics: Clarithromycin; Drug Therapy, Combination; Foot Dermatoses; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifampin; Skin; Skin Diseases, Bacterial | 2004 |
Comparison of clinical features in patients with pulmonary Mycobacterium-avium complex (MAC) disease treated before and after proposal for guidelines.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Japan; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Outcome Assessment, Health Care; Practice Guidelines as Topic; Rifampin; Saliva; Sex Distribution; Streptomycin | 2004 |
Concentration of clarithromycin and 14-R-hydroxy-clarithromycin in plasma of patients with Mycobacterium avium complex infection, before and after the addition of rifampicin.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Therapy, Combination; Female; Humans; Liver; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin; Time Factors | 2004 |
Mycobacterium bohemicum--a cause of paediatric cervical lymphadenitis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Child, Preschool; Clarithromycin; Female; Humans; Rifampin; Tuberculosis, Lymph Node | 2004 |
Female genital tract Mycobacterium chelonae infection.
Topics: Abortion, Spontaneous; Adult; Antitubercular Agents; Clarithromycin; Diagnosis, Differential; Female; Genital Diseases, Female; Humans; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Pregnancy; Rifampin | 2004 |
Recurrent acute rheumatic fever: a forgotten diagnosis?
Topics: Acute Disease; Adult; Amoxicillin; Anti-Inflammatory Agents; Aortic Valve; Aortic Valve Insufficiency; Arthralgia; Bangladesh; Clarithromycin; Diagnosis, Differential; Diagnostic Errors; Drug Therapy, Combination; Emigration and Immigration; Endocarditis, Bacterial; England; Female; Fever; Gentamicins; Heart Failure; Heart Valve Prosthesis Implantation; Humans; Penicillin G; Penicillin V; Pericarditis; Pharyngitis; Prednisone; Recurrence; Rheumatic Fever; Rheumatic Heart Disease; Rifampin; Unnecessary Procedures; Vancomycin | 2004 |
Mycobacterium marinum infections of the upper extremity.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Ethambutol; Female; Hand; Hand Injuries; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Retrospective Studies; Rifampin | 2005 |
Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Colony Count, Microbial; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Quinolones; Rifampin | 2005 |
[Pulmonary infection due to Mycobacterium malmoense].
Topics: Azithromycin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin | 2005 |
Osteomyelitis of the mandible due to Mycobacterium abscessus: a case report.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Mandibular Diseases; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Osteomyelitis; Rifampin; Root Canal Therapy | 2005 |
[Mycobacterium marinum tenosynovitis of the abductors].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Female; Hand Injuries; Humans; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifampin; Tenosynovitis; Time Factors; Treatment Outcome | 2005 |
Helicobacter pylori infection rate in patients with nontuberculous mycobacteriosis who are on longterm combination chemotherapy of clarithromycin and rifampicin.
Topics: Aged; Aged, 80 and over; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Middle Aged; Mycobacterium Infections; Rifampin | 2005 |
Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Synergism; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2005 |
Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
Topics: Amikacin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Clarithromycin; Clofazimine; Cycloserine; DNA Fingerprinting; DNA, Bacterial; Doxycycline; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifabutin; Rifampin; Streptomycin | 2005 |
[A case of Mycobacterium intracellulare lung disease that was detected by health examination and was successfully cured by chemotherapy--including discussions on the diagnostic criteria of the disease].
Topics: Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Magnetic Resonance Imaging; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Tomography, X-Ray Computed | 2005 |
Antimicrobial activity of picolinic acid against extracellular and intracellular Mycobacterium avium complex and its combined activity with clarithromycin, rifampicin and fluoroquinolones.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Clarithromycin; Drug Synergism; Epithelial Cells; Female; Fluoroquinolones; Humans; Macrophages; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium avium Complex; Picolinic Acids; Pulmonary Alveoli; Rifampin | 2006 |
Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
Topics: Adult; Antibiotics, Antitubercular; Ciprofloxacin; Clarithromycin; Cycloserine; Ethambutol; Ethionamide; Female; Humans; Israel; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Ofloxacin; Prognosis; Rifampin | 2006 |
[A case of Mycobacterium intracellulare infection with chronic empyema].
Topics: Aged, 80 and over; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Empyema; Ethambutol; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiography, Thoracic; Rifampin; Streptomycin; Tomography, X-Ray Computed | 2006 |
Case report of non-healing wounds presenting to a DGH, South East London.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifampin; Skin Diseases, Bacterial; Thumb; Treatment Outcome | 2006 |
Impact of rifampicin addition to clarithromycin in Legionella pneumophila pneumonia.
Topics: Aged; Anti-Bacterial Agents; Bilirubin; Clarithromycin; Cohort Studies; Disease Outbreaks; Drug Therapy, Combination; Female; Humans; Legionella pneumophila; Legionnaires' Disease; Length of Stay; Male; Middle Aged; Rifampin; Spain | 2006 |
The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study.
Topics: Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Guideline Adherence; Humans; Incidence; Japan; Male; Middle Aged; Mycobacterium avium Complex; Retrospective Studies; Rifampin; Sputum; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2007 |
Intracellular success: cytologic findings in an ulcerated submandibular mass from a cat.
Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clarithromycin; Male; Rhodococcus equi; Rifampin; Treatment Outcome | 2006 |
The expanding spectrum of Mycobacterium avium complex-associated pulmonary disease.
Topics: Adult; Amikacin; Biopsy; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Granuloma; Humans; Lung; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Necrosis; Pneumonia, Bacterial; Prednisone; Rifampin; Sputum; Tomography, X-Ray Computed | 2006 |
[Basic evaluation for new antimicrobial susceptibility testing of Mycobacterium leprae by bioluminescence assay (ATP method)].
Topics: Animals; Clarithromycin; Clofazimine; Drug Resistance, Bacterial; Leprostatic Agents; Leprosy; Luciferases; Luminescent Agents; Mice; Mice, Nude; Microbial Sensitivity Tests; Mycobacterium leprae; Ofloxacin; Rifampin | 2006 |
Growth in catheter biofilms and antibiotic resistance of Mycobacterium avium.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Catheterization; Clarithromycin; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Polyvinyl Chloride; Rifampin | 2007 |
Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor therapy.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antitubercular Agents; Arthritis, Rheumatoid; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Therapy, Combination; Etanercept; Ethambutol; Humans; Immunoglobulin G; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Receptors, Tumor Necrosis Factor; Rifampin; Sputum; Thoracotomy; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha | 2007 |
[Measurement of rifampicin and clarithromycin in serum by high-performance liquid chromatography with electrochemical detection].
Topics: Aged; Chromatography, High Pressure Liquid; Clarithromycin; Electrochemistry; Female; Humans; Liver; Rifampin | 2007 |
Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.
Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Delivery Systems; Ethambutol; Female; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Specific Pathogen-Free Organisms; Tuberculosis | 2007 |
[Clinical analysis of drug interaction between rifampicin and clarithromycin which are used for treating pulmonary Mycobacterium avium complex infection].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Drug Interactions; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin; Tuberculosis, Pulmonary | 2007 |
[Case of pulmonary infection with Mycobacterium chelonae in healthy breast-feeding woman].
Topics: Adult; Antitubercular Agents; Breast Feeding; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Isoniazid; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2007 |
[A case of pulmonary infection due to Mycobacterium chelonae treated by lobectomy after a long course of oral antimicrobial agents].
Topics: Antibiotics, Antitubercular; Clarithromycin; Ethambutol; Female; Humans; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Pneumonectomy; Rifampin; Tuberculosis, Pulmonary | 2007 |
Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Dietary Supplements; Digoxin; Echinacea; Flavonoids; Ginkgo biloba; Herb-Drug Interactions; Hypericum; Rifampin | 2008 |
Effect of benzathine penicillin treatment on antibiotic susceptibility of viridans streptococci in oral flora of patients receiving secondary prophylaxis after rheumatic fever.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antibiotics, Antitubercular; Child; Clarithromycin; Clindamycin; Drug Administration Schedule; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Israel; Male; Microbial Sensitivity Tests; Mouth; Penicillin G Benzathine; Rheumatic Fever; Rifampin; Secondary Prevention; Streptococcal Infections; Viridans Streptococci | 2008 |
[Clinical efficacy of kanamycin for Mycobacterium avium complex disease].
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Kanamycin; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin | 2008 |
Bactericidal and sterilizing activities of several orally administered combined regimens against Mycobacterium ulcerans in mice.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Aza Compounds; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Female; Fluoroquinolones; Mice; Mice, Inbred BALB C; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Quinolines; Rifampin; Treatment Outcome | 2008 |
Diagnostic pitfall: Mycobacterium avium complex pulmonary infection and positive ANCA.
Topics: Antibiotics, Antitubercular; Antibodies, Antineutrophil Cytoplasmic; Biopsy; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Sputum; Thoracic Surgery, Video-Assisted; Tuberculosis, Pulmonary; Vasculitis | 2008 |
Management of Mycobacterium ulcerans infection in a pregnant woman in Benin using rifampicin and clarithromycin.
Topics: Adult; Antibiotics, Antitubercular; Benin; Buruli Ulcer; Clarithromycin; Female; Humans; Mycobacterium ulcerans; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Skin Transplantation | 2008 |
Non-tuberculous mycobacterial osteomyelitis: an unusual cause of hip pain in immunocompetent children.
Topics: Anti-Bacterial Agents; Arthralgia; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Humans; Immunocompetence; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Osteomyelitis; Rifampin; Treatment Outcome | 2009 |
[Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Practice Guidelines as Topic; Recurrence; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2008 |
Simultaneous determination of clarithromycin, rifampicin and their main metabolites in human plasma by liquid chromatography-tandem mass spectrometry.
Topics: Anti-Bacterial Agents; Chromatography, Liquid; Clarithromycin; Humans; Rifampin; Tandem Mass Spectrometry | 2009 |
Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchiectasis; Clarithromycin; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
[High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children].
Topics: Adolescent; Amoxicillin; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Rifampin; Spain; Tetracycline | 2009 |
Disseminated infection with Bartonella henselae in a lung transplant recipient.
Topics: Adult; Anti-Bacterial Agents; Bartonella henselae; Cat-Scratch Disease; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Lung; Lung Transplantation; Magnetic Resonance Imaging; Rifampin; Treatment Outcome | 2009 |
An uncommon cause for a common complaint.
Topics: Anti-Bacterial Agents; Carpal Tunnel Syndrome; Clarithromycin; DNA, Bacterial; Ethambutol; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Occupational Exposure; Rifampin; Rivers; Tenosynovitis | 2009 |
Sporotrichoid Mycobacterium marinum infection of the face following a cat scratch.
Topics: Animals; Antibiotics, Antitubercular; Blood Sedimentation; C-Reactive Protein; Cats; Clarithromycin; Drug Therapy, Combination; Face; Female; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifampin; Tuberculosis, Cutaneous; Young Adult | 2010 |
Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Clarithromycin; Drug Synergism; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxins; Rifampin | 2010 |
Antimicrobial drugs for Buruli ulcer.
Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Drug Therapy, Combination; Ghana; Humans; Mice; Rifampin; Streptomycin | 2010 |
Painful Buruli ulcer in a Malian visitor to France.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Drug Therapy, Combination; France; Humans; Leg Ulcer; Male; Mali; Mycobacterium ulcerans; Pain; Rifampin; Travel; Treatment Outcome | 2010 |
Standardized combination antibiotic treatment of Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium; Mycobacterium Infections; Retrospective Studies; Rifampin; Streptomycin; Treatment Outcome | 2010 |
Panniculitis attributable to Mycobacterium goodii in an immunocompetent dog in Georgia.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Dog Diseases; Dogs; Female; Georgia; Immunocompetence; Mycobacterium; Mycobacterium Infections, Nontuberculous; Panniculitis; Rifampin | 2010 |
Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benin; Buruli Ulcer; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium ulcerans; Pilot Projects; Rifampin; Treatment Outcome; Young Adult | 2011 |
Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice.
Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Rifampin; Treatment Outcome | 2011 |
A case report of a patient with rheumatoid arthritis complicated with Mycobacterium avium during tocilizumab treatment.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antitubercular Agents; Arthritis, Rheumatoid; Clarithromycin; Ethambutol; Female; Humans; Middle Aged; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Rifampin; Treatment Outcome | 2011 |
Validation parameters cannot be obtained without using pure substance.
Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Clarithromycin; Horse Diseases; Pulmonary Alveoli; Respiratory Tract Infections; Rifampin | 2011 |
Oral absorption of clarithromycin is nearly abolished by chronic comedication of rifampicin in foals.
Topics: Absorption; Animals; ATP-Binding Cassette Transporters; Bronchi; Cholesterol; Clarithromycin; Drug Interactions; Epithelial Cells; Horses; Hydroxycholesterols; Lung; Mouth Mucosa; Multidrug Resistance-Associated Protein 2; Organic Anion Transporters; Pregnane X Receptor; Receptors, Steroid; Rifampin; RNA, Messenger | 2011 |
[Immune reconstitution syndrome related to a Mycobacterium avium complex infection, revealed by a mono-adenitis].
Topics: Abscess; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Axilla; Clarithromycin; Darunavir; Dideoxynucleosides; Enfuvirtide; Ethambutol; HIV Envelope Protein gp41; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Isoniazid; Lamivudine; Lymph Node Excision; Lymphadenitis; Male; Mycobacterium avium-intracellulare Infection; Peptide Fragments; Pyrazinamide; Rifampin; Ritonavir; Streptomycin; Sulfonamides | 2011 |
Tattoo-associated Mycobacterium haemophilum skin infection in immunocompetent adult, 2009.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Contact Tracing; Drug Therapy, Combination; Humans; Male; Mycobacterium haemophilum; Mycobacterium Infections; Rifampin; Skin Diseases, Bacterial; Tattooing; Treatment Outcome; Washington | 2011 |
Effect of amphotericin B alone or in combination with rifampicin or clarithromycin against Candida species biofilms.
Topics: Amphotericin B; Anti-Bacterial Agents; Biofilms; Candida; Clarithromycin; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Rifampin | 2011 |
[Mycobacterium massiliense bone infection].
Topics: Cicatrix; Clarithromycin; Debridement; Diabetes Mellitus, Type 2; Disease Susceptibility; Femoral Fractures; Fracture Fixation, Internal; Fractures, Closed; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Osteomyelitis; Osteotomy; Ribotyping; Rifampin; Surgical Wound Infection; Vancomycin | 2012 |
Buruli ulcer accompanied by pain in a Japanese patient.
Topics: Anti-Bacterial Agents; Asian People; Buruli Ulcer; Clarithromycin; Drug Therapy, Combination; Face; Female; Humans; Middle Aged; Mycobacterium ulcerans; Ofloxacin; Pain; Rifampin | 2012 |
Clarithromycin is absorbed by an intestinal uptake mechanism that is sensitive to major inhibition by rifampicin: results of a short-term drug interaction study in foals.
Topics: Animals; Clarithromycin; Drug Interactions; Female; HEK293 Cells; Horses; Humans; Intestinal Absorption; Intestinal Mucosa; Intestines; Lung; Male; Organic Anion Transporters; Respiratory Mucosa; Rifampin; Transfection; Up-Regulation | 2012 |
Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period.
Topics: Aged; Antitubercular Agents; Clarithromycin; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum.
Topics: Amikacin; Anti-Infective Agents; Clarithromycin; Computer Simulation; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Models, Biological; Models, Theoretical; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifampin; Tuberculosis | 2012 |
Discitis and sacroiliitis diagnosed 15 years after iatrogenic Mycobacterium xenopi inoculation.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Cross Infection; Discitis; Disease Outbreaks; Diskectomy, Percutaneous; Drug Therapy, Combination; Ethambutol; Humans; Immunocompetence; Magnetic Resonance Imaging; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Rifampin; Sacroiliitis; Surgical Wound Infection; Treatment Outcome | 2012 |
Nonirritant intradermal skin test concentrations of ciprofloxacin, clarithromycin, and rifampicin.
Topics: Adult; Allergens; Ciprofloxacin; Clarithromycin; Female; Humans; Male; Middle Aged; Regional Blood Flow; Rifampin; Skin Test End-Point Titration; Young Adult | 2012 |
[Swelling of right knee in an immunologically compromised patient].
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Arthritis, Infectious; Bacteremia; Candidiasis, Oral; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Immunocompromised Host; Isoniazid; Knee Joint; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Radiography; Rifampin; Tuberculosis, Osteoarticular | 2012 |
Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient.
Topics: Adult; Antitubercular Agents; Clarithromycin; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; HIV Seronegativity; Humans; Isoniazid; Kanamycin; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2012 |
The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.
Topics: Adult; Aged; Amikacin; Antibiotics, Antitubercular; Area Under Curve; Clarithromycin; Cohort Studies; Colorado; Drug Interactions; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Retrospective Studies; Rifabutin; Rifampin | 2012 |
A case of wrist tenosynovitis caused by Mycobacterium kansasii in a renal transplant recipient.
Topics: Clarithromycin; Ethambutol; Humans; Kidney Transplantation; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Optic Neuritis; Rifampin; Tenosynovitis; Wrist | 2012 |
Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Ethambutol; Female; Humans; Logistic Models; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Republic of Korea; Retrospective Studies; Rifabutin; Rifampin | 2012 |
[A study of adverse drug reactions in the treatment of pulmonary Mycobacterium avium complex disease].
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary | 2012 |
Troubleshooting carry-over of LC-MS/MS method for rifampicin, clarithromycin and metabolites in human plasma.
Topics: Chromatography, Liquid; Clarithromycin; Humans; Linear Models; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Tandem Mass Spectrometry | 2013 |
[Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report].
Topics: Adult; Clarithromycin; Cysts; Ethambutol; Humans; Isoniazid; Lung Diseases; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Rifampin; Tuberculosis, Pulmonary | 2012 |
Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen.
Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Drug Resistance, Bacterial; Ethambutol; Female; Fluoroquinolones; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolines; Rifampin; Sputum | 2013 |
Cutaneous Mycobacterium intracellulare infection in an immuno-competent person.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; Chaperonin 60; Clarithromycin; DNA, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Immunocompetence; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Polymerase Chain Reaction; Ribotyping; Rifampin; RNA, Ribosomal, 16S; Skin; Skin Diseases, Bacterial | 2013 |
Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
Topics: Animals; Anti-Infective Agents; CHO Cells; Clarithromycin; Computer Simulation; Cricetulus; Cytochrome P-450 Enzyme System; Drug Interactions; Fluconazole; Glyburide; HEK293 Cells; Humans; Hypoglycemic Agents; Models, Biological; Rifampin | 2013 |
Mastitis caused by Mycobacterium kansasii infection in a dog.
Topics: Animals; Anti-Bacterial Agents; Biopsy, Fine-Needle; Clarithromycin; Dog Diseases; Dogs; Fatal Outcome; Female; Humans; Lung; Lymphoma; Macrophages; Mammary Glands, Human; Mastitis; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin | 2013 |
Mycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Australia; Buruli Ulcer; Ciprofloxacin; Clarithromycin; Cohort Studies; Debridement; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mycobacterium ulcerans; Retrospective Studies; Rifampin; Treatment Outcome | 2013 |
Clinical outcome of the chronic flexor tenosynovitis in the hand caused by non-tuberculous mycobacterium treated by extensive tenosynovectomy and drugs.
Topics: Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Hand; Hand Strength; Humans; Immunocompetence; Isoniazid; Levofloxacin; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Mycobacterium marinum; Osteomyelitis; Range of Motion, Articular; Retrospective Studies; Rifampin; Scaphoid Bone; Synovectomy; Tenosynovitis | 2013 |
Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi.
Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Gentamicins; Horse Diseases; Horses; Macrolides; Microbial Sensitivity Tests; Mutation; Rhodococcus equi; Rifampin; Vancomycin | 2013 |
Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Clarithromycin; Disease Progression; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Male; Middle Aged; Multiple Pulmonary Nodules; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Proportional Hazards Models; Retrospective Studies; Rifampin; Tomography, X-Ray Computed | 2013 |
Salvage therapy for multidrug-resistant tuberculosis.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Capreomycin; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Male; Moxifloxacin; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Salvage Therapy; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Buruli Ulcer; Child; Child, Preschool; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Female; Ghana; Humans; Middle Aged; Mycobacterium ulcerans; Rifampin; Skin; Streptomycin; Treatment Outcome | 2014 |
Changes in serum immunomolecules during antibiotic therapy for Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Cytokines; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifampin; Th1 Cells; Th17 Cells; Th2 Cells | 2014 |
Tenosynovitis of the right hand. Mycobacterium kansasii.
Topics: Anti-Bacterial Agents; C-Reactive Protein; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Fingers; Humans; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Physical Examination; Rifampin; Tenosynovitis | 2013 |
Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report.
Topics: Adalimumab; Administration, Oral; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Clarithromycin; Ethambutol; Glucocorticoids; Humans; Male; Mycobacterium; Mycobacterium Infections; Polychondritis, Relapsing; Rifampin; Tacrolimus; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC-MS/MS.
Topics: Chromatography, Liquid; Clarithromycin; Reproducibility of Results; Rifampin; Tandem Mass Spectrometry | 2014 |
Prevention of biofilm formation by methacrylate-based copolymer films loaded with rifampin, clarithromycin, doxycycline alone or in combination.
Topics: Anti-Bacterial Agents; Biofilms; Bioreactors; Clarithromycin; Delayed-Action Preparations; Doxycycline; Drug Carriers; Drug Combinations; Drug Liberation; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Polymethyl Methacrylate; Polystyrenes; Rifampin; Surface Properties | 2015 |
An unusual lung mass post stem cell transplantation.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin; Stem Cell Transplantation | 2014 |
Compliance with antimicrobial therapy for buruli ulcer.
Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Female; Humans; Mycobacterium ulcerans; Rifampin; Streptomycin | 2014 |
Reply to "compliance with antimicrobial therapy for buruli ulcer".
Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Female; Humans; Mycobacterium ulcerans; Rifampin; Streptomycin | 2014 |
Successful renal transplant in patient with controlled pulmonary non-tuberculous mycobacterium infection.
Topics: Antibiotics, Antitubercular; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Middle Aged; Mycobacterium Infections, Nontuberculous; Recurrence; Rifampin; Treatment Outcome | 2014 |
The influence of environmental exposure on the response to antimicrobial treatment in pulmonary Mycobacterial avium complex disease.
Topics: Aged; Antitubercular Agents; Clarithromycin; Environmental Exposure; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Recurrence; Retrospective Studies; Rifampin; Soil Microbiology; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2014 |
Mycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients?
Topics: Adjuvants, Immunologic; Adult; Aged; Antibiotics, Antitubercular; Australia; Buruli Ulcer; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium ulcerans; Retrospective Studies; Rifampin; Risk Factors; Treatment Outcome; Withholding Treatment | 2015 |
Efficacy of liposomal gentamicin against Rhodococcus equi in a mouse infection model and colocalization with R. equi in equine alveolar macrophages.
Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Gentamicins; Horse Diseases; Horses; Liposomes; Liver; Macrophages, Alveolar; Male; Mice; Mice, Nude; Pneumonia; Rhodococcus equi; Rifampin; Spleen | 2015 |
Exploration of a standard treatment for Buruli ulcer through a comprehensive analysis of all cases diagnosed in Japan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Buruli Ulcer; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Humans; Japan; Levofloxacin; Male; Middle Aged; Rifampin; Young Adult | 2015 |
Activity of clarithromycin or rifampin alone or in combination against experimental Rhodococcus equi infection in mice.
Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Combinations; Male; Mice; Mice, Nude; Microbial Sensitivity Tests; Rhodococcus equi; Rifampin | 2015 |
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease.
Topics: Animals; Buruli Ulcer; Clarithromycin; Clofazimine; Colony Count, Microbial; Drug Evaluation, Preclinical; Drug Therapy, Combination; Foot; Macrolides; Mice; Microbial Sensitivity Tests; Rifampin; Streptomycin; Survival Analysis; Time Factors; Treatment Outcome | 2015 |
From a fish tank injury to hospital haemodialysis: the serious consequences of drug interactions.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Interactions; Ethambutol; Finger Injuries; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mycobacterium Infections, Nontuberculous; Renal Dialysis; Rhabdomyolysis; Rifampin; Simvastatin | 2015 |
Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for atorvastatin and its metabolites.
Topics: Area Under Curve; Atorvastatin; Cimetidine; Clarithromycin; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Itraconazole; Models, Biological; Phenytoin; Rifampin | 2015 |
Intracranial abscess due to Mycobacterium avium complex in an immunocompetent host: a case report.
Topics: Adult; Anti-Bacterial Agents; Brain Abscess; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 2015 |
Sporotrichoid Mycobacterium marinum infection in an elderly woman.
Topics: Aged, 80 and over; Animals; Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Doxycycline; Drug Therapy, Combination; Female; Fishes; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifampin; Skin | 2015 |
Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacteremia; Ciprofloxacin; Clarithromycin; Disease Models, Animal; Doxycycline; Drug Combinations; Drug Synergism; Humans; Imipenem; Linezolid; Male; Microbial Sensitivity Tests; Rabbits; Respiratory Tract Infections; Rifampin; Spores, Bacterial; Survival Analysis; Vancomycin | 2015 |
Cat scratch disease of the parotid gland.
Topics: Anti-Bacterial Agents; Cat-Scratch Disease; Child; Clarithromycin; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Parotitis; Rifampin | 2016 |
Successful resumption of tocilizumab for rheumatoid arthritis after resection of a pulmonary Mycobacterium avium complex lesion: a case report.
Topics: Amikacin; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Clarithromycin; Ethambutol; Female; Humans; Immunocompromised Host; Lung; Middle Aged; Mycobacterium avium-intracellulare Infection; Pneumonectomy; Rifampin; Tomography, X-Ray Computed | 2015 |
Pharmacokinetics and Pulmonary Distribution of Clarithromycin and Rifampicin after Concomitant and Consecutive Administration in Foals.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Drug Interactions; HEK293 Cells; Horses; Humans; Lung; Rifampin; Tissue Distribution | 2016 |
Nontuberculous Mycobacterial Disease in Children - Epidemiology, Diagnosis & Management at a Tertiary Center.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Cohort Studies; DNA, Bacterial; Female; Humans; Infant; Infant, Newborn; Lymphadenitis; Male; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Mycobacterium ulcerans; Retrospective Studies; Rifampin; Skin Diseases; Soft Tissue Infections; Tertiary Care Centers | 2016 |
Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Biological Assay; Biological Transport; Cell Membrane; Cephalosporins; Clarithromycin; Drug Synergism; Escherichia coli; Escherichia coli Proteins; Fluorescent Dyes; Gene Expression; Imidazoles; Indicators and Reagents; Kinetics; Levofloxacin; Linezolid; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Oxacillin; Piperazines; Protein Kinases; Repressor Proteins; Rifampin | 2016 |
Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Australia; Buruli Ulcer; Clarithromycin; Cohort Studies; Female; Fluoroquinolones; Humans; Male; Middle Aged; Mycobacterium ulcerans; Prospective Studies; Rifampin; Victoria; Young Adult | 2016 |
Miliary pulmonary nodules due to Mycobacterium xenopi in a steroid-induced immunocompromised patient successfully treated with chemotherapy: a case report.
Topics: Adult; Bronchoalveolar Lavage Fluid; Clarithromycin; Ethambutol; Humans; Immunocompromised Host; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Rifampin; Sputum; Tomography, X-Ray Computed | 2016 |
The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance?
Topics: Animals; Anti-Bacterial Agents; Biofilms; Clarithromycin; Daptomycin; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Foreign Bodies; Microbial Sensitivity Tests; Microbial Viability; Rats; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2017 |
[Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment].
Topics: Clarithromycin; Diagnosis, Differential; Ethambutol; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Respiratory Tract Infections; Rifampin; Tuberculosis, Pulmonary | 2017 |
Transporter-Mediated Hepatic Uptake Plays an Important Role in the Pharmacokinetics and Drug-Drug Interactions of Montelukast.
Topics: Acetates; Animals; Clarithromycin; Cyclopropanes; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Gemfibrozil; Haplorhini; Hepatocytes; Liver; Liver-Specific Organic Anion Transporter 1; Models, Biological; Nucleic Acid Synthesis Inhibitors; Organic Anion Transporters; Quinolines; Rats; Rifampin; Sulfides | 2017 |
Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in Mice.
Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Diarylquinolines; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred BALB C; Moxifloxacin; Mycobacterium ulcerans; Rifampin | 2016 |
Pulmonary Mycobacterium marinum infection: 'fish tank granuloma' of the lung.
Topics: Aged; Animals; Antibiotics, Antitubercular; Clarithromycin; Cough; Ethambutol; Fishes; Humans; Lethargy; Male; Mycobacterium Infections, Nontuberculous; Pulmonary Disease, Chronic Obstructive; Rifampin; Treatment Outcome; Wastewater; Weight Loss | 2016 |
Nothing to (S)cough at: Pulmonary Mycobacterium avium Complex Infection.
Topics: Anti-Bacterial Agents; Bronchiectasis; Chest Pain; Clarithromycin; Cough; Drug Therapy, Combination; Dyspnea; Ethambutol; Humans; Leukocytosis; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Tracheobronchomegaly; Veterans | 2017 |
Pulmonary and Vertebral Mycobacterium avium Disease in a HIV-negative 71-year-old Man - A Case Report.
Topics: Aged; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Humans; Lung Diseases; Male; Mycobacterium avium; Mycobacterium Infections, Nontuberculous; Respiratory Insufficiency; Rifampin; Risk Factors; Spinal Diseases; Sputum | 2016 |
Effects of clarithromycin, azithromycin and rifampicin on terbutaline-induced sweating in foals.
Topics: Animals; Azithromycin; Clarithromycin; Horses; Rifampin; Sweating; Terbutaline | 2017 |
The clinical efficacy of a clarithromycin-based regimen for Mycobacterium avium complex disease: A nationwide post-marketing study.
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Marketing; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Sputum; Treatment Outcome | 2017 |
SAPHO syndrome-like presentation of disseminated nontuberculous mycobacterial infection in a case with neutralizing anti-IFNγ autoantibody.
Topics: Acquired Hyperostosis Syndrome; Anti-Bacterial Agents; Autoantibodies; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Interferon-gamma; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin; Treatment Outcome | 2017 |
Mycobacterium gordonae Skin Infection in an Immunocompetent Child.
Topics: Anti-Bacterial Agents; Child, Preschool; Clarithromycin; Dermatologic Surgical Procedures; Ethambutol; Face; Humans; Immunocompetence; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Skin | 2017 |
Feline leprosy due to Candidatus 'Mycobacterium tarwinense':Further clinical and molecular characterisation of 15 previously reported cases and an additional 27 cases
Topics: Animals; Cat Diseases; Cats; Clarithromycin; Female; Leprostatic Agents; Leprosy; Male; Mycobacterium; Prospective Studies; Retrospective Studies; Rifampin; Victoria | 2017 |
Clarithromycin, rifampicin and fusidic acid triple combination therapy for chronic folliculocentric pustulosis of the scalp.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Folliculitis; Fusidic Acid; Humans; Male; Propionibacterium acnes; Remission Induction; Retrospective Studies; Rifampin; Scalp; Staphylococcus aureus; Treatment Outcome | 2017 |
Disseminated Mycobacterium scrofulaceum Infection in an Immunocompetent Host.
Topics: Antitubercular Agents; Clarithromycin; Ethambutol; Female; Humans; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium scrofulaceum; Osteomyelitis; Rifampin | 2017 |
Efficacy and tolerability of culture-guided treatment for Helicobacter pylori infection.
Topics: Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Body Mass Index; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Rifampin; Tetracycline | 2017 |
Mycobacterium shimoidei-cavitary pulmonary disease with favorable outcome.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Croatia; Female; Humans; Lung Diseases; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Streptomycin; Treatment Outcome | 2018 |
Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software.
Topics: Ciprofloxacin; Clarithromycin; Computer Simulation; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inducers; Drug Interactions; Fluconazole; Humans; Itraconazole; Ketoconazole; Models, Biological; Paroxetine; Quinidine; Rifampin; Software | 2018 |
Disseminated Cutaneous Infection of Mycobacterium colombiense in a Patient with Myelodysplastic Syndrome.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Ethambutol; Humans; Immunocompromised Host; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Myelodysplastic Syndromes; Rifampin; Treatment Outcome | 2018 |
Novel Linear Lipopeptide Paenipeptins with Potential for Eradicating Biofilms and Sensitizing Gram-Negative Bacteria to Rifampicin and Clarithromycin.
Topics: Anti-Bacterial Agents; Biofilms; Clarithromycin; Drug Synergism; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hemolysis; Humans; Lipopeptides; Microbial Sensitivity Tests; Paenibacillus; Rifampin; Structure-Activity Relationship | 2017 |
Genotyping and drug susceptibility testing of mycobacterial isolates from population-based tuberculosis prevalence survey in Ghana.
Topics: Adolescent; Adult; Aged; Clarithromycin; Drug Resistance, Bacterial; Female; Genotype; Ghana; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Prevalence; Retrospective Studies; Rifampin; Surveys and Questionnaires; Tuberculosis | 2017 |
Disseminated Mycobacterium marinum skin infection due to chronic lymphedema in an immunocompetent patient.
Topics: Biopsy; Chronic Disease; Clarithromycin; Dermis; Diagnosis, Differential; Doxycycline; Drug Therapy, Combination; Epidermis; Female; Humans; Immunocompetence; Leg Dermatoses; Lymphedema; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin | 2018 |
Mycobacterium marinum infections in Denmark from 2004 to 2017: A retrospective study of incidence, patient characteristics, treatment regimens and outcome.
Topics: Adult; Clarithromycin; Diagnosis, Differential; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Retrospective Studies; Rifampin; Skin Diseases, Bacterial; Treatment Outcome | 2018 |
Lipopeptide Paenipeptin Analogues Potentiate Clarithromycin and Rifampin against Carbapenem-Resistant Pathogens.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cell Survival; Clarithromycin; Drug Combinations; Drug Synergism; HEK293 Cells; Humans; Klebsiella pneumoniae; Lipopeptides; Microbial Sensitivity Tests; Rifampin | 2018 |
The stability of antimycobacterial drugs in media used for drug susceptibility testing.
Topics: Anti-Bacterial Agents; Clarithromycin; Culture Media, Conditioned; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Stability; Humans; Microbial Sensitivity Tests; Mycobacterium; Rifampin | 2018 |
PBPK Models for CYP3A4 and P-gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and Digoxin.
Topics: Alfentanil; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Cytochrome P-450 CYP3A; Digoxin; Drug Interactions; Humans; Itraconazole; Midazolam; Models, Biological; Rifampin | 2018 |
An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP+.
Topics: Anti-Bacterial Agents; Clarithromycin; Fluoroquinolones; Humans; Leprosy; Moxifloxacin; Netherlands; Post-Exposure Prophylaxis; Rifampin | 2018 |
Emergence of Resistance to Macrolides and Rifampin in Clinical Isolates of Rhodococcus equi from Foals in Central Kentucky, 1995 to 2017.
Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Equidae; Erythromycin; Feces; Horses; Kentucky; Microbial Sensitivity Tests; Musculoskeletal Diseases; Prevalence; Respiratory System; Rhodococcus equi; Rifampin; Soft Tissue Infections | 2019 |
Splenic granulomas: a rare manifestation of
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Diagnosis, Differential; Ethambutol; Granuloma; Humans; Immunocompromised Host; Male; Mycobacterium avium Complex; Polymerase Chain Reaction; Rifampin; Spleen; Splenic Diseases | 2018 |
Small-Cell Lung Cancer Comorbid with Pulmonary Mycobacterium avium Infection: A Case Report.
Topics: Aged; Animals; Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Bronchoscopy; Clarithromycin; Drug Therapy, Combination; Etoposide; Humans; Lung; Lung Neoplasms; Male; Mycobacterium avium; Peptide Fragments; Recombinant Proteins; Rifampin; Small Cell Lung Carcinoma; Tomography, X-Ray Computed; Tuberculosis, Avian | 2018 |
Mycobacterium genavense Infection in a Domestic Ferret (Mustela putorius furo).
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Conjunctivitis, Bacterial; Female; Ferrets; Fluoroquinolones; Mycobacterium; Mycobacterium Infections; Polymerase Chain Reaction; Rifampin; RNA, Ribosomal, 16S | 2018 |
Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer.
Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Disease Models, Animal; Female; Linezolid; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Oxazolidinones; Rifampin; Tetrazoles | 2019 |
Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening.
Topics: Administration, Oral; Amoxicillin; beta-Lactamase Inhibitors; beta-Lactamases; Buruli Ulcer; Clarithromycin; Clavulanic Acid; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Mycobacterium ulcerans; Rifampin | 2019 |
Drug resistance and pathogenic spectrum of patients coinfected with nontuberculous mycobacteria and human-immunodeficiency virus in Chengdu, China.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; Antitubercular Agents; China; Clarithromycin; Ethambutol; Female; HIV Infections; HIV-1; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium Complex; Nontuberculous Mycobacteria; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Young Adult | 2019 |
A case of cutaneous nodules in a sporotrichoid pattern.
Topics: Aged; Anti-Bacterial Agents; Biopsy; Clarithromycin; Culture Techniques; Forearm; Hand Dermatoses; Humans; Male; Mycobacterium Infections, Nontuberculous; Rifampin; Skin Diseases, Bacterial | 2019 |
Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Buruli Ulcer; Clarithromycin; Clofazimine; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Electron Transport; Humans; Imidazoles; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium ulcerans; Piperidines; Pyridines; Rifampin; Streptomycin | 2019 |
Nontuberculous lymphadenitis in children: What management strategy?
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Child, Preschool; Clarithromycin; Drainage; Drug Therapy, Combination; Female; Humans; Infant; Lymphadenitis; Male; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Neck; Retrospective Studies; Rifampin | 2019 |
Postinjection abscesses and granulomas in children adopted from Russia.
Topics: Abscess; Child, Adopted; Clarithromycin; Europe, Eastern; Female; Granuloma; Humans; Infant; Injections, Intramuscular; Rifampin; Risk Assessment; Russia; Skin Diseases; USSR | 2019 |
Providing insight into the incubation period of Mycobacterium ulcerans disease: two case reports.
Topics: Administration, Oral; Antibiotics, Antitubercular; Buruli Ulcer; Clarithromycin; Drug Therapy, Combination; Ghana; Humans; Infant, Newborn; Infectious Disease Incubation Period; Mycobacterium ulcerans; Polymerase Chain Reaction; Rifampin | 2019 |
Mycobacterium kansasii arthritis of the elbow in an immunocompetent patient with a suspected soft-tissue tumor.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Clarithromycin; Diagnosis, Differential; Elbow Joint; Ethambutol; Humans; Immunocompetence; Magnetic Resonance Imaging; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin; Soft Tissue Neoplasms; Treatment Outcome | 2020 |
Paenipeptin Analogues Potentiate Clarithromycin and Rifampin against
Topics: Animals; Bacterial Outer Membrane; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Mice; Polymyxins; Rifampin | 2020 |
Predicting Clinical Effects of CYP3A4 Modulators on Abemaciclib and Active Metabolites Exposure Using Physiologically Based Pharmacokinetic Modeling.
Topics: Administration, Oral; Adult; Aged; Alkynes; Aminopyridines; Area Under Curve; Benzimidazoles; Benzoxazines; Bosentan; Clarithromycin; Computer Simulation; Cyclin-Dependent Kinases; Cyclopropanes; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Diltiazem; Drug Interactions; Female; Healthy Volunteers; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Modafinil; Models, Biological; Rifampin; Verapamil | 2020 |
Buruli ulcer: cured by 8 weeks of oral antibiotics?
Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Humans; Rifampin; Streptomycin | 2020 |
Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Japan; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prognosis; Respiratory Tract Infections; Retrospective Studies; Rifampin; Sputum; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence; Japan; Macrolides; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Negative Results; Pneumonia, Bacterial; Rifampin | 2020 |
The Bairnsdale ulcer (Mycobacterium ulcerans) in an urban Victorian practice: A case series.
Topics: Adolescent; Aged; Antibiotics, Antitubercular; Buruli Ulcer; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium ulcerans; Rifampin; Victoria | 2020 |
Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy.
Topics: Animals; Asymptomatic Infections; Bacterial Load; Clarithromycin; Drug Combinations; Leprostatic Agents; Leprosy; Mice; Mice, Nude; Minocycline; Moxifloxacin; Mycobacterium leprae; Post-Exposure Prophylaxis; Rifampin | 2020 |
Mycobacterium marinum infection in an immunocompromised patient with infliximab.
Topics: Anti-Inflammatory Agents; Clarithromycin; Colitis, Ulcerative; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Immunocompromised Host; Infliximab; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin | 2020 |
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Clarithromycin; Ethambutol; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nucleic Acid Amplification Techniques; Polymyalgia Rheumatica; Polyps; Prednisolone; Pulmonary Atelectasis; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pulmonary | 2020 |
Survey of the antimicrobial resistance of Helicobacter pylori in France in 2018 and evolution during the previous 5 years.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; France; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Rifampin | 2021 |
Proline Hinged Amphipathic α-Helical Peptide Sensitizes Gram-Negative Bacteria to Various Gram-Positive Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cell Membrane; Clarithromycin; Escherichia coli; Female; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Linezolid; Lipid A; Membrane Fluidity; Mice, Inbred ICR; Microbial Sensitivity Tests; Proline; Protein Binding; Protein Conformation, alpha-Helical; Rifampin | 2020 |
Quantitative Assessment of Levonorgestrel Binding Partner Interplay and Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling.
Topics: Adult; Alkynes; Benzoxazines; Body Mass Index; Carbamazepine; Clarithromycin; Computer Simulation; Contraceptives, Oral, Combined; Cyclopropanes; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Itraconazole; Levonorgestrel; Models, Biological; Obesity; Rifampin; Sex Hormone-Binding Globulin | 2021 |
The influence of P-glycoprotein expression in the standard treatment of Helicobacter pylori infection in Sprague Dawley rats.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Cyclosporine; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Male; Omeprazole; Proton Pump Inhibitors; Rats, Sprague-Dawley; Rifampin; Stomach Ulcer | 2021 |
Detection of Helicobacter pylori by invasive tests in adult dyspeptic patients and antibacterial resistance to six antibiotics, including rifampicin in Turkey. Is clarithromycin resistance rate decreasing?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Rifampin; Turkey; Young Adult | 2021 |
Drug susceptibiity testing of nontuberculous mycobacteria by broth microdilution method.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Humans; India; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin | 2021 |
Efficacy of an Acid-Oxidizing Solution against Mycobacterium ulcerans.
Topics: Buruli Ulcer; Clarithromycin; Humans; Mycobacterium ulcerans; Oxidation-Reduction; Rifampin | 2022 |
Impact of rifampicin on the pharmacokinetics of clarithromycin and 14-hydroxy clarithromycin in patients with multidrug combination therapy for pulmonary Mycobacterium avium complex infection.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 2022 |
Drug resistance profiles and related gene mutations in slow-growing non-tuberculous mycobacteria isolated in regional tuberculosis reference laboratories of Iran: a three year cross-sectional study.
Topics: Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Humans; Iran; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Tuberculosis | 2023 |
Implementation of a Clostridioides difficile sentinel surveillance system in Germany: First insights for 2019-2021.
Topics: Anti-Bacterial Agents; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Ribotyping; Rifampin; Sentinel Surveillance | 2022 |
Synergistic activity and molecular modelling of fosfomycin combinations with some antibiotics against multidrug resistant Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Fosfomycin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Rifampin | 2022 |
Topics: Anti-Bacterial Agents; Clarithromycin; Clostridioides difficile; Drug Resistance, Bacterial; Fidaxomicin; Humans; Macrolides; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin | 2022 |
Analysis of adverse drug events in pulmonary Mycobacterium avium complex disease using spontaneous reporting system.
Topics: Clarithromycin; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Japan; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 2022 |
Brucellosis: A Rare Cause of Febrile Neutropenia in a Child.
Topics: Anti-Bacterial Agents; Brucellosis; C-Reactive Protein; Cefuroxime; Child; Child, Preschool; Clarithromycin; Febrile Neutropenia; Female; Fever; Humans; Meropenem; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 2021.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Resistance, Bacterial; Fosfomycin; Furazolidone; Gatifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ornidazole; Rifampin; Tinidazole | 2022 |
Topics: Adult; Buruli Ulcer; Clarithromycin; Humans; Lung; Male; Mycobacterium ulcerans; Rifampin | 2022 |
Antibiotic resistance patterns of Helicobacter pylori strains isolated from the Tibet Autonomous Region, China.
Topics: Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Rifampin; Tetracycline; Tibet | 2022 |
Challenging diagnosis and successful treatment of localised
Topics: Alkaline Phosphatase; Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; Clavulanic Acid; Dog Diseases; Dogs; Doxycycline; Female; Glossitis; Immunomodulation; Mycobacterium; Mycobacterium avium; Rifampin | 2022 |
Antibiotic resistance patterns of Helicobacter pylori in North Israel - A six-year study.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Rifampin | 2022 |
Anti-Mycobacterial Activity of Flavonoid and Pyrimidine Compounds.
Topics: Antitubercular Agents; Clarithromycin; Cycloserine; Drug Combinations; Flavonoids; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium tuberculosis; Pyrimidines; Rifampin; Tuberculosis | 2022 |
Roles of Lipopolysaccharide Glycosyltransferases in Maintenance of
Topics: Amoxicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cell Wall; Clarithromycin; Glycosyltransferases; Helicobacter Infections; Helicobacter pylori; Humans; Lipopolysaccharides; Metronidazole; Microbial Sensitivity Tests; Permeability; Rifampin | 2023 |